Professor Geoffrey McCaughan

A W Morrow Professor in Medicine
Medicine, Central Clinical School
Centenary Institute of Cancer Medicine & Cell Biology

Telephone +61 2 9515 8578
Fax +61 2 9515 5182

Website Related website

Map

Selected grants

2014

  • The Role of the Hepatocyte and EMMPRIN in Liver Injury; Shackel N, McCaughan G, McLennan S; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Protease therapies for diabetes-associated liver disease; Gorrell M, Keane F, Cook A, Shackel N, Seth D, Chen J, Jolly C, Hare N, McCaughan G; Rebecca L Cooper Medical Research Foundation/Equipment Grant.

2013

  • Leica PowerMosaic plus microsope upgrade for flexible, high-resolution slide scanning; Gamble J, McCaughan G, Feng C, Fazekas B, Weninger W, Shackel N, Bertolino P, Lovelace M, Saunders B, Armati P, Pollard J, Pai S, Arnold J, Triccas J, Goldsbury C, Bailey C, Mrass P, Rasko J, Biro M; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • QIAxcel high throughput automated DNA, RNA and protein capillary electrophoresis system; Weninger W, Fazekas B, Feng C, Jolly C, Semsarian C, Vadas M, Bertolino P, McCaughan G, Shackel N, Bagnall R, Shklovskaya E, Bailey C; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2012

  • Targeting proteases for a novel therapy for type 2 diabetes and liver complications.; Gorrell M, Twigg S, McLennan S, McCaughan G, Chowdhury S; Diabetes Australia Research Trust/Research Grants.
  • BD Influx 3-L Cell Sorter; Britton W, King N, Grau G, Weninger W, McCaughan G, Slobedman B, Saunders B, West N, Triccas J, Abendroth A, Combes V, Bowen D, Shackel N, Ellis M; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Novel outcome predictors in HCV post-liver transplant; Gorrell M, McCaughan G; Australian Centre for Hepatitis and HIV Virology Research (ACH2)/HIV and Hepatitis C Virology and Immunology Research Grants.

2010

  • High speed 3D live cell imaging of cancer genesis, growth, metastasis and death.; Weninger W, Vadas M, Richardson D, Fazekas B, Gamble J, McCaughan G, Rasko J, Shackel N, Haass N; Cancer Institute New South Wales/Equipment Grant.
  • The role of the hepatocyte hedgehog pathway in progressive liver injury; McCaughan G, Shackel N, Warner F; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Next-generation high-speed flow cytometric cell sorter; Fazekas B, King N, Simpson S, Britton W, Campbell I, Vadas M, Grau G, Weninger W, Christopherson R, Gamble J, Rasko J, McCaughan G, Xia P, Beale P, Holst J, Haass N, Combes V, Saunders B, Byrne S, West N, Gorrell M, Bertolino P, Bowen D, Warner F, Seth D, Grimshaw M, Jolly C, Martiniello-Wilks R, Mrass P, Lyons G, Sword G; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Inflammation, Angiogenesis and Cancer; Vadas M, McCaughan G, Gamble J, Bertolino P, Xia P; National Health and Medical Research Council (NHMRC)/Program Grants.

2009

  • Core Resource Facility - application for 7-laser flow cytometer and high content bioimaging system to enhance capabilities and throughput for the NSW Advanced Cytometry Facility; King N, Vadas M, Campbell I, Grau G, Britton W, Fazekas B, Richardson D, Halliday G, Christopherson R, Gamble J, Mason R, Rasko J, McCaughan G, Weninger W, Xia P, Gorrell M, Holst J, Pile A, Sword G, McArthur C, Dong Q, Haass N, Sharland A, Saunders B, Triccas J, Norris J, Bertolino P, Bowen D, Sze D; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Inverted Multiphoton Intravital Microscope; Weninger W, Gorrell M, Halliday G, Jones C, Fazekas B, Richardson D, Clarke S, Gamble J, Bertolino P, Vadas M, Dong Q, Rasko J, Holst J, McCaughan G, Byrne S, Saunders B, Triccas J, Haass N; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Multi-photon microscope for intravital imaging; Weninger W, Vadas M, Hogg P, Norris M, Fazekas B, Haass N, Clarke S, Halliday G, Rasko J, Holst J, McCaughan G, Allen J, Gamble J, Dong Q, Byrne S, Richardson D; Cancer Institute New South Wales/Equipment Grant.

2008

  • Epidemiology, prevention and management of liver cancer in NSW: Towards a strategic research partner; McCaughan G, George J, Strasser S, Dore G, Liddle C; Cancer Council New South Wales/Strategic Research Partnership (STREP) Grants.
  • Epidemiology, prevention and management of liver cancer in NSW: Towards a strategic research partnership; Strasser S, George J, McCaughan G, Dore G, Liddle C, Strasser S; Cancer Council New South Wales/Strategic Research Partnership (STREP) Grants.

2007

  • Role of tryptophan metabolism in liver transplant tolerance and rejection; Bishop A, Hall B, McCaughan G, Sharland A, Alexander I, Earl J, Hall B; National Health and Medical Research Council (NHMRC)/Project Grants.

2006

  • Refridgerated incubator and analytical apparatus; McCaughan G; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2005

  • Molecular and cellular pathogenesis of liver disease; George J, McCaughan G; National Health and Medical Research Council (NHMRC)/Program Grants.
  • Gastroenterology research; McCaughan G; Miscellaneous Generic Research/Research Project Support.
  • Human biology of dipeptidyl peptidases; McCaughan G; University of Sydney/Research & Development.
  • Medical Foundation funding to support a NHMRC Program Grant No 358398. Entitled - Molecular & cellular pathogenesis of liver disease; Farrell G, McCaughan G, George J; University of Sydney/Internal Research Grant Allocations - Medicine.
  • Enzyme Inhibition Test for Dipeptidyl Peptidases 8 & 9 (TPL); Tadayyon M, Gorrell M, McCaughan G; Torrent Pharmaceuticals Ltd India (India)/BLO Project.
  • FACS Aria for the University of Sydney Flow Cytometry Facility; King N, Pollard J, Rasko J, Lovicu F, Bishop A, Bertolino P, Briscoe H, Gillies M, Madigan M, McAvoy J, Murphy C, Balcar V, Armour C, Hughes M, Reeve V, Christopherson R, Halliday G, Christie M, Pollock C, McCaughan G, Gorrell M, Dong Q, Abendroth A, Menzies S, Barnetson R, Byrne S, Hunt N, Hambly B, Cook D, Mason R, Day M, Black J; University of Sydney/Equipment Grant.

2004

  • An integrated approach to application of novel developments in basic transplantation research to cli; Chadban S, Hennessy A, Allen R, McCaughan G, Bishop A, Sharland A, Eris J; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Basic mechanism of spontaneous tolerance of liver allografts in a rat model; Wang C, Bishop A, McCaughan G, Rasko J, Sharland A; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • Centre of clinical research excellence to improve outcomes in chronic liver disease; Farrell G, McCaughan G, George J, Donaghy A, Strasser S, Strasser S, Donaghy A; National Health and Medical Research Council (NHMRC)/Centre of Clinical Research Excellence.
  • Nucleic Acid Extraction Facility; Bishop A, McCaughan G, Gorrell M, Halliday G; Rebecca L Cooper Medical Research Foundation/Equipment Grant.
  • Molecular Pathogenesis of alcoholic liver disease; Haber P, Gorrell M, McCaughan G; Hlth & Medical Research Grants/Research Grant.

2001

  • Development of clinically applicable strategies to induce and monitor long term acceptance of liver; Jonsson J, Bishop A, McCaughan G, Powell E; National Health and Medical Research Council (NHMRC)/Project Grants.

1998

  • Automated quantitation of gene expression using an applied biosystems model 7700 sequence detector; Bishop A, McCaughan G, Garsia R, Iland H, Halliday G; Wellcome Trust (UK)/Major Equipment Awards for Biomedical Research in Australia.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Thompson, A., McHutchison, J., McCaughan, G. (2012). New Horizons: IL28, Direct-acting Antiviral Therapy for HCV. In Geoffrey W. McCaughan, John G. McHutchison, Jean-Michel Pawlotsky (Eds.), Advanced Therapy for Hepatitis C, (pp. 196-213). Chichester, United Kingdom: Wiley-Blackwell Publishing.
  • Keane, F., Chowdhury, S., Yao, T., Nadvi, N., Gall, M., Chen, Y., Osborne, B., Ribeiro, A., Church, W., McCaughan, G., Gorrell, M., Yu, M. (2012). Targeting Dipeptidyl Peptidase-4 (DPP-4) and Fibroblast Activation Protein (FAP) for Diabetes and Cancer Therapy. In Ben Dunn (Eds.), Proteinases as Drug Targets, (pp. 118-144). Cambridge, UK: RSC Publishing.
  • Bowen, D., Zekry, A., Bertolino, P., Shackel, N., McCaughan, G. (2009). Pathology and pathogenesis of hepatitis C. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 43-75). East Hawthorn, Victoria: IP Communications.
  • Bertolino, P., McCaughan, G., Bowen, D. (2008). Immunological Parameters Influencing Adaptive Immune Responses to the Hepatitis C Virus. In Emilio Jirillo (Eds.), Hepatitis C Virus Disease: Immunobiology and Clinical Applications, (pp. 39-70). United States: Springer.
  • McCaughan, G., Shackel, N., Williams, R., Seth, D., Haber, P., Gorrell, M. (2007). Genomics, gene arrays and proteomics in the study of liver disease. In Juan Rodes, Jean-Pierre Benhamou, Andres Blei, Juerg Reichen, and Mario Rizzetto (Eds.), The Textbook of Hepatology: From Basic Science to Clinical Practice, (pp. 398-420). USA: Blackwell Publishers.
  • Lanzetta, M., Kubitskiy, A., Bishop, A., Li, J., McCaughan, G. (2007). Simultaneous vascularized bone marrow transplantation to promote acceptance of limb allografts. In Lanzetta M; Dubernard J (Eds.), Hand Transplantation, (pp. 57-59). Italy: Springer.
  • Bertolino, P., Bowen, D., Zen, M., McCaughan, G. (2005). Autoimmune hepatitis in transgenic mouse models: what lessons can be learnt? In H. P. Dienes, U. Leuschner, A. W. Lohse, M. P. Manns (Eds.), Autoimmune Liver Disease: Proceedings of the Falk Symposium No. 142, (pp. 60-72). The Netherlands: Springer.
  • Chen, T., Ajami, K., McCaughan, G., Gorrell, M., Abbott, C. (2003). Dipeptidyl peptidase IV gene family. In M. Hildebrandt, B. F. Klapp, T. Hoffman and H.-U. Demuth (Eds.), Dipeptidyl Aminopeptidases in Health and Disease, (pp. 79-88). NY: Springer.
  • Gorrell, M., Wang, X., Levy, M., Kable, E., Marinos, G., Cox, G., McCaughan, G. (2003). Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infection. In M. Hildebrandt, B. F. Klapp, T. Hoffman and H.-U. Demuth (Eds.), Dipeptidyl Aminopeptidases in Health and Disease, (pp. 235-243). NY: Springer.
  • Ajami, K., Abbott, C., Gysbers, V., Kaehne, T., McCaughan, G., Gorrell, M. (2003). Molecular chimeras and mutational analysis in the prolyl oligopeptidase gene family. In M. Hildebrandt, B. F. Klapp, T. Hoffman and H.-U. Demuth (Eds.), Dipeptidyl Aminopeptidases in Health and Disease, (pp. 49-55). NY: Springer.

Journals

  • Shackel, N., Vadas, M., Gamble, J., McCaughan, G. (2014). Beyond Liver Fibrosis: Hepatic Stellate Cell Senescence Links Obesity to Liver Cancer by Way of the Microbiome. Hepatology, 59(6), 2413-2415. [More Information]
  • Roberts, S., Mitchell, J., Leung, R., Booth, D., Bollipo, S., Ostapowicz, G., Sloss, A., McCaughan, G., Dore, G., Thompson, A., George, J., et al (2014). Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies. Journal of Gastroenterology and Hepatology, 29(1), 179-184. [More Information]
  • Keane, F., Tsun-Wen, Y., Seelk, S., Gall, M., Chowdhury, S., Poplawski, S., Lai, J., Li, Y., Wu, W., Farrell, P., Vieira de Ribeiro, A., Osborne, B., Yu, M., Seth, D., Haber, P., Wang, C., Thomson, S., Twigg, S., McLennan, S., McCaughan, G., Gorrell, M., et al (2014). Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio, 4, 43-54. [More Information]
  • Grzelak, C., Martelotto, L., Sigglekow, N., Patkunanathan, B., Ajami, K., Calabro, S., Dwyer, B., Tirnitz-Parker, J., Watkins, D., Warner, F., Shackel, N., McCaughan, G. (2014). The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. Journal of Hepatology, 60(1), 143-151. [More Information]
  • Tu, T., Shackel, N., McCaughan, G. (2013). "Testing your methyl": DNA methylation profiling of serum DNA of HCC patients. Hepatology International, 7(3), 785-787. [More Information]
  • Bendorf, A., Kelly, P., Kerridge, I., McCaughan, G., Myerson, B., Stewart, C., Pussell, B. (2013). An International Comparison of the Effect of Policy Shifts to Organ Donation following Cardiocirculatory Death (DCD) on Donation Rates after Brain Death (DBD) and Transplantation Rates. PLoS One, 8(5), 1-7. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Author reply: RE Terlipressin therapy for moderate to severe hyponatraemia in patients with liver failure. Internal Medicine Journal, 43(5), 607-607. [More Information]
  • Gane, E., Patterson, S., Strasser, S., McCaughan, G., Angus, P. (2013). Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transplantation, 19(3), 268-274. [More Information]
  • Na, R., Grulich, A., Meagher, N., McCaughan, G., Keogh, A., Vajdic, C. (2013). Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients. American Journal of Transplantation, 13(1), 174-183. [More Information]
  • McCaughan, G. (2013). Current Management of HBV Pre and Post Liver Transplant. Current Hepatitis Reports, 12(2), 119-123. [More Information]
  • Na, R., Grulich, A., Meagher, N., McCaughan, G., Keogh, A., Vajdic, C. (2013). De novo Cancer-Related Death in Australian Liver and Cardiothoracic Transplant Recipients. American Journal of Transplantation, 13(5), 1296-1304. [More Information]
  • McCaughan, G., Vajdic, C. (2013). De novo malignant disease after liver transplantation? Risk and surveillance strategies. Liver Transplantation, 19(Suppl. 2), S62-S67. [More Information]
  • Tay, S., Lu, B., Sierro, F., Benseler, V., McGuffog, C., Bishop, A., Cowan, P., McCaughan, G., Dwyer, K., Bowen, D., et al (2013). Differential migration of passenger leukocytes and rapid deletion of naive alloreactive CD8 T cells after mouse liver transplantation. Liver Transplantation, 19(11), 1224-1235. [More Information]
  • McCaughan, G. (2013). Early hepatocellular carcinoma - is there such a thing as too early? Journal of Hepatology, 58(2), 210-211. [More Information]
  • Cunningham, E., Tay, S., Wang, C., Rtshiladze, M., Wang, Z., McGuffog, C., Cubitt, J., McCaughan, G., Alexander, I., Bertolino, P., Sharland, A., Bowen, D., Bishop, A. (2013). Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts. Transplantation, 95(1), 70-77. [More Information]
  • Berenguer, M., McCaughan, G. (2013). Hepatitis C virus-associated cholestatic hepatitis: We cannot seem to agree on diagnostic criteria. Liver Transplantation, 19(2), 115-117. [More Information]
  • Verran, D., Mulheam, M., Dilworth, P., Balderson, G., Munn, S., Chen, J., Fink, M., Crawford, M., McCaughan, G. (2013). Nature and outcomes of the increased incidence of colorectal malignancy after liver transplantation in Australasia. Medical Journal of Australia, 199(9), 610-612. [More Information]
  • McCaughan, G., Bowen, D., Bertolino, P. (2013). Operational tolerance in liver transplantation: Shall we predict or promote? Liver Transplantation, 19(9), 933-936. [More Information]
  • Saunderson, R., Garsia, R., Headley, A., McCaughan, G., O'Toole, S., Strasser, S. (2013). Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. Journal of Dermatological Case Reports, 7(3), 77-81. [More Information]
  • Chowdhury, S., Chen, Y., Yao, T., Ajami, K., Wang, X., Popov, Y., Schuppan, D., Bertolino, P., McCaughan, G., Yu, M., Gorrell, M. (2013). Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. World Journal of Gastroenterology, 19(19), 2883-2893. [More Information]
  • Young, J., Ting, K., Li, J., Moller, T., Dunn, L., Lu, Y., Moses, J., Prado-Lourenco, L., Khachigian, L., Ng, M., Lichtenstein, I., Tran, N., Shackel, N., Kench, J., McCaughan, G., Vadas, M., Gamble, J., et al (2013). Regulation of vascular leak and recovery from ischaemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood, 122(16), 2911-2919. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Terlipressin Therapy for Moderate to Severe Hyponatremia in Patients with Liver Failure. Internal Medicine Journal, 43(3), 240-246. [More Information]
  • Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]
  • Kitson, M., Dore, G., George, J., Button, P., McCaughan, G., Crawford, D., Sievert, W., Weltman, M., Cheng, W., Roberts, S. (2013). Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology, 58(3), 467-472. [More Information]
  • Lau, E., McCaughan, G., Torzillo, P. (2012). A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations. Internal Medicine Journal, 42(5), 600-601. [More Information]
  • Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012). Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International, 32(10), 1527-1534. [More Information]
  • Omata, M., Kanda, T., Yu, M., Yokosuka, O., Lim, S., Jafri, W., Tateishi, R., Hamid, S., Chuang, W., Chuttaputti, A., McCaughan, G., et al (2012). APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatology International, 6(2), 409-435. [More Information]
  • McCaughan, G., Vajdic, C., Grulich, A. (2012). Cancer risk after organ transplantation. JAMA, 307(7), 663; author reply 663-664. [More Information]
  • Ganbold, A., Andersen, S., Tay, S., Cunningham, E., Ilie, V., Krishnan, S., Wang, C., McCaughan, G., Sharland, A., Bishop, A. (2012). Expression of common gamma chain signalling cytokines and their receptors distinguishes rejection from tolerance in a rat organ transplant model. Transplant Immunology, 27(2-3), 89-94. [More Information]
  • Graaf, E., Kench, J., Dilworth, P., Shackel, N., Strasser, S., Joseph, D., Pleass, H., Crawford, M., McCaughan, G., Verran, D. (2012). Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. Journal of Gastroenterology and Hepatology, 27(3), 540-546. [More Information]
  • McCaughan, G. (2012). Is the end of chronic hepatitis C virus infection in sight? Medical Journal of Australia, 196(10), 614-614. [More Information]
  • Holz, L., Benseler, V., Vo, M., McGuffog, C., Van Rooijen, N., McCaughan, G., Bowen, D., Bertolino, P. (2012). Naive CD8 T cell activation by liver bone marrow-derived cells leads to a "neglected" IL-2(low) Bim(high) phenotype, poor CTL function and cell death. Journal of Hepatology, 57(4), 830-836. [More Information]
  • McCaughan, G. (2012). New therapies against HCV: Expected risks and challenges associated with their use in the liver transplant setting. Journal of Hepatology, 57(6), 1361-1367. [More Information]
  • Bishop, A., Bertolino, P., Bowen, D., McCaughan, G. (2012). Tolerance in liver transplantation. Best Practice & Research: Clinical Gastroenterology, 26(1), 73-84. [More Information]
  • McCaughan, G. (2012). Trekking new ground: Overcoming medical and social impediments for extended criteria liver transplant recipients. Liver Transplantation, 18(11 Supp 2 (November)), S39-S46. [More Information]
  • Barbier, L., Tay, S., McGuffog, C., Triccas, J., McCaughan, G., Bowen, D., Bertolino, P. (2012). Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. Journal of Hepatology, 57(2), 352-358. [More Information]
  • Yao, T., Kim, W., Yu, D., Sharbeen, G., McCaughan, G., Choi, K., Xia, P., Gorrell, M. (2011). A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling. Molecular Cancer Research, 9(7), 948-959. [More Information]
  • Sievert, W., Altraif, I., Razavi, H., Abdo, A., Ahmed, E., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., McCaughan, G., et al (2011). A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver International, 31(Suppl 2), 61-80. [More Information]
  • Bishop, A., Ierino, F., Sharland, A., Hall, B., Alexander, S., Sandrin, M., Coates, P., McCaughan, G. (2011). Approaching the promise of operational tolerance in clinical transplantation. Transplantation, 91(10), 1065-1074. [More Information]
  • Lo, L., McLennan, S., Williams, P., Bonner, J., Chowdhury, S., McCaughan, G., Gorrell, M., Yue, D., Twigg, S. (2011). Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. Journal of Hepatology, 55(2), 435-444. [More Information]
  • Song, S., Shackel, N., Wang, X., Ajami, K., McCaughan, G., Gorrell, M. (2011). Discoidin Domain Receptor 1: Isoform expression and potential functions in cirrhotic human liver. The American Journal of Pathology: cellular and molecular biology of disease, 178(3), 1134-1144. [More Information]
  • Baleriola, C., Rawlinson, W., Dore, G., Chaverot, S., Stelzer-Braid, S., Yoshihara, M., Crawford, D., Sievert, W., McCaughan, G., Weltman, M., et al (2011). Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients. Antiviral Therapy, 16(2), 173-180. [More Information]
  • Poustchi, H., Farrell, G., Strasser, S., Lee, A., McCaughan, G., George, J. (2011). Feasibility of conducting a randomised control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology, 54(6), 1998-2004. [More Information]
  • Benseler, V., Warren, A., Vo, M., Holz, L., Tay, S., Le Couteur, D., Breen, E., Allison, A., Van Rooijen, N., McGuffog, C., Bowen, D., McCaughan, G., Bertolino, P., et al (2011). Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 108(40), 16735-16740. [More Information]
  • McCaughan, G., Shackel, N., Bowen, D. (2011). Liver transplantation and hepatitis C: will understanding the interleukin-28B polymorphisms improve outcomes? Liver Transplantation, 17(3), 219-221. [More Information]
  • Bishop, A., Sharland, A., Ierino, F., Sandrin, M., Hall, B., Alexander, S., Coates, P., McCaughan, G. (2011). Operational Tolerance in Organ Transplantation Versus Tissue Engineering: Into the Future. Transplantation, 92(8), e39-e39. [More Information]
  • McCaughan, G., Bowen, D. (2011). Pathogenesis of cholestatic hepatitis C. Journal of Hepatology, 54, 392-394. [More Information]
  • McCaughan, G. (2011). Prevention of post liver transplant HBV recurrence. Hepatology International, 5(4), 876-881. [More Information]
  • Gamble, J., Vadas, M., McCaughan, G. (2011). Sinusoidal endothelium is essential for liver regeneration. Hepatology, 54(2), 731-733. [More Information]
  • Yu, M., Slaitini, L., Gysbers, V., Riekhoff, A., Kähne, T., Knott, H., De Meester, I., Abbott, C., McCaughan, G., Gorrell, M. (2011). Soluble CD26/Dipeptidyl Peptidase IV Enhances Human Lymphocyte Proliferation In Vitro Independent of Dipeptidyl Peptidase Enzyme Activity and Adenosine Deaminase Binding. Scandinavian Journal of Immunology, 73(2), 102-111. [More Information]
  • Wang, C., Cordoba, S., Hu, M., Bertolino, P., Bowen, D., Sharland, A., Allen, R., Alexander, S., McCaughan, G., Bishop, A. (2011). Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments. Transplant Immunology, 24(3), 149-156. [More Information]
  • Gorrell, M., Zekry, A., McCaughan, G., Lloyd, A. (2011). The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infection. Hepatology, 54(5), 1875-1879. [More Information]
  • Wang, C., Tay, S., Tran, G., Hodgkinson, S., Allen, R., Hall, B., McCaughan, G., Sharland, A., Bishop, A. (2010). Donor IL-4 treatment induces alternatively activated liver macrophages and IDO-Expressing NK cells and promotes rat liver allograft acceptance. Transplant Immunology, 22(3-4), 172-178. [More Information]
  • Dore, G., Hellard, M., Matthews, G., Grebely, J., Haber, P., Petoumenos, K., Yeung, B., Marks, P., van Beek, I., McCaughan, G., et al (2010). Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology, 138(1), 123-135.e1-2. [More Information]
  • Lau, E., McCaughan, G., Torzillo, P. (2010). Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism. Liver Transplantation, 16(7), 870-873. [More Information]
  • Prakoso, E., Verran, D., Dilworth, P., Kyd, G., Tang, P., Tse, C., Koorey, D., Strasser, S., Stormon, M., Shun, A., Allen, R., et al (2010). Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Internal Medicine Journal, 40(9), 619-625. [More Information]
  • Cheng, W., Roberts, S., McCaughan, G., Sievert, W., Weltman, M., Crawford, D., Rawlinson, W., Marks, P., Thommes, J., Rizkalla, B., et al (2010). Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing. Journal of Hepatology, 53(4), 616-623. [More Information]
  • McCaughan, G., Shackel, N., Strasser, S., Dilworth, P., Tang, P. (2010). Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transplantation, 16(2), 130-137. [More Information]
  • McCaughan, G. (2010). Organ donation in Australia. Internal Medicine Journal, 40(8), 603-604. [More Information]
  • Shackel, N., Bowen, D., McCaughan, G. (2010). Snipping away at hepatitis C. Hepatology, 51(2), 703-705. [More Information]
  • Yu, M., Yao, T., Chowdhury, S., Nadvi, N., Osborne, B., Church, W., McCaughan, G., Gorrell, M. (2010). The dipeptidyl peptidase IV family in cancer and cell biology. The FEBS Journal, 277(5), 1126-1144. [More Information]
  • Eckersley-Maslin, M., Grzelak, C., McCaughan, G., Shackel, N. (2009). Bone marrow stem cells and the liver: are they relevant? Journal of Gastroenterology and Hepatology, 24(10), 1608-1616. [More Information]
  • Matthews, G., Hellard, M., Haber, P., Yeung, B., Marks, P., Baker, D., McCaughan, G., Sasadeusz, J., White, P., Rawlinson, W., et al (2009). Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C. Clinical Infectious Diseases, 48(5), 650-658. [More Information]
  • Rauch, A., James, I., Pfafferott, K., Nolan, D., Klenerman, P., Cheng, W., Mollison, L., McCaughan, G., Shackel, N., Jeffrey, G., et al (2009). Diverged Adaptation of Hepatitis C Virus Genotypes 1 and 3 to Human Leukocyte Antigen-Restricted Immune Pressure. Hepatology, 50(4), 1017-1029. [More Information]
  • Sandroussi, C., Crawford, M., Lockwood, D., Tang, P., Gallagher, J., Pleass, H., Strasser, S., Shackel, N., McCaughan, G., Verran, D. (2009). Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients. Liver Transplantation, 15(11), 1586-1593. [More Information]
  • Shackel, N., Jamias, J., Rahman, W., Prakoso, E., Strasser, S., Koorey, D., Crawford, M., Verran, D., Gallagher, J., McCaughan, G. (2009). Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C–Related Liver Failure Post–Liver Transplantation. Liver Transplantation, 15(7), 709-718. [More Information]
  • Laurence, J., McCaughan, G., Logan, G., Alexander, I., Bishop, A., Sharland, A. (2009). Gene therapy in transplantation. Transplantation Reviews, 23(3), 159-170. [More Information]
  • Gaudieri, S., Rauch, A., Pfafferott, K., Barnes, E., McCaughan, G., Shackel, N., Cheng, W., Jeffrey, G., Mollison, L., Baker, R., et al (2009). Hepatitis C Virus Drug Resistance and Immune-Driven Adaptations: Relevance to New Antiviral Therapy. Hepatology, 49(4), 1069-1082. [More Information]
  • Roberts, S., Weltman, M., Crawford, D., McCaughan, G., Sievert, W., Cheng, W., Rawlinson, W., Desmond, P., Marks, P., Yoshihara, M., et al (2009). Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology, 50(4), 1045-1055. [More Information]
  • McCaughan, G., Shackel, N., Bertolino, P., Bowen, D. (2009). Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes. Transplantation, 87(8), 1105-1111. [More Information]
  • Laurence, J., Wang, C., Zheng, M., Cunningham, S., Earl, J., Tay, S., Allen, R., McCaughan, G., Alexander, I., Bishop, A., Sharland, A. (2009). Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transplantation, 15(2), 233-241. [More Information]
  • Yu, M., Ajami, K., Gall, M., Park, J., Lee, C., Evans, K., McLaughlin, E., Pitman, M., Abbott, C., McCaughan, G., Gorrell, M. (2009). The In Vivo Expression of Dipeptidyl Peptidases 8 and 9. Journal of Histochemistry and Cytochemistry: imaging the spectrum of cell biology, 57(11), 1025-1040. [More Information]
  • Geenen, I., Sosef, M., Shun, A., Crawford, M., Gallagher, J., Strasser, S., Stormon, M., McCaughan, G., Verran, D. (2009). Usage and Outcomes of Deceased Donor Liver Allografts with Preprocurement Injury from Blunt Trauma. Liver Transplantation, 15(3), 321-325. [More Information]
  • Angus, P., Patterson, S., Strasser, S., McCaughan, G., Gane, E. (2008). A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis. Hepatology, 48(5), 1460-1466. [More Information]
  • McCaughan, G. (2008). Adrenal insufficiency and liver disease - Re-search. Journal of Hepatology, 48(6), 1018. [More Information]
  • Laurence, J., Wang, C., Park, E., Buchanan, A., Clouston, A., Allen, R., McCaughan, G., Bishop, A., Sharland, A. (2008). Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection. Transplantation, 85(9), 1357-1361. [More Information]
  • Alghamdi, H., Crawford, M., Gallagher, J., McCaughan, G., Strasser, S., Verran, D. (2008). Cadaveric liver transplant from older donors. Saudi Medical Journal, 29(4), 533-538. [More Information]
  • Devanshi, S., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2008). Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. Journal of Hepatology, 48(4), 614-627. [More Information]
  • Wang, X., Yao, T., Nadvi, N., Osborne, B., McCaughan, G., Gorrell, M. (2008). Fibroblast activation protein and chronic liver disease. Frontiers in Bioscience, 13, 3168-3180. [More Information]
  • Lam, V., Taylor, C., Laurence, J., Wang, C., Sharland, A., McCaughan, G., Hodgkinson, S., Allen, R., Hall, B., Bishop, A. (2008). Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: Effect on foxp3 and cytokine expression and graft infiltration. Transplant Immunology, 19(1), 20-24. [More Information]
  • Shackel, N., McCaughan, G., Warner, F. (2008). Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin-6 signaling. Hepatology, 47(6), 2134-2136. [More Information]
  • Neuman, M., Sha, K., Esguerra, R., Zakhari, S., Winkler, R., Hilzenrat, N., Wyse, J., Cooper, C., Seth, D., Gorrell, M., Haber, P., McCaughan, G., et al (2008). Inflammation and Repair in Viral Hepatitis C. Digestive diseases and sciences, 53(6), 1468-1487. [More Information]
  • Holz, L., Benseler, V., Bowen, D., Bouillet, P., Strasser, A., O'Reilly, L., D'Avigdor, W., Bishop, A., McCaughan, G., Bertolino, P. (2008). Intrahepatic Murine CD8 T-Cell Activation Associates With a Distinct Phenotype Leading to Bim-Dependent Death. Gastroenterology, 135(3), 989-997. [More Information]
  • Holz, L., McCaughan, G., Benseler, V., Bertolino, P., Bowen, D. (2008). Liver tolerance and the manipulation of immune outcomes. Inflammation and Allergy: Drug Targets, 7(1), 6-18. [More Information]
  • Vadas, M., Xia, P., McCaughan, G., Gamble, J. (2008). The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction? BBA - Bioenergetics, 1781 (9), 442-447. [More Information]
  • Haber, P., McCaughan, G. (2007). "I'll never touch it again, doctor!" - harmful drinking after liver transplantation. Hepatology, 46(4), 1302-1304. [More Information]
  • McCaughan, G., Omata, M., Amarapurkar, D., Bowden, S., Chow, W., Chutaputti, A., Dore, G., Gane, E., Guan, R., Hamid, S., et al (2007). Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 22(5), 615-633. [More Information]
  • van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
  • Labio, E., Del Rosario, D., Strasser, S., McCaughan, G., Crawford, B. (2007). Effect of Ascites on Bone Density Measurement in Cirrhosis. Journal of Clinical Densitometry: Assessment of Skeletal Health, 10(4), 391-394. [More Information]
  • Cua, I., Hui, J., Bandara, P., Kench, J., Farrell, G., McCaughan, G., George, J. (2007). Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology, 46(1), 66-73. [More Information]
  • Shackel, N., McCaughan, G. (2007). Intrahepatic interferon-stimulated gene responses: Can they predict treatment responses in chronic hepatitis C infection? Hepatology (Baltimore Md.), 46(5), 1326-8. [More Information]
  • Warner, F., Lubel, J., McCaughan, G., Angus, P. (2007). Liver fibrosis: a balance of ACEs? Clinical Science, 113(3), 109-118. [More Information]
  • Perry, J., Charlton, B., Koorey, D., Waugh, R., Gallagher, P., Crawford, M., Verran, D., McCaughan, G., Strasser, S. (2007). Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International, 27(9), 1240-1248. [More Information]
  • Kubitskiy, A., Li, J., Lanzetta, M., Owen, E., McCaughan, G., Bishop, A. (2007). Simultaneous Vascularized Bone Marrow Transplantation to Promote Acceptance of Hind Limb Allografts and Its Effects on Central and Peripheral Chimerism. Transplantation, 83(9), 1273-1276. [More Information]
  • Benseler, V., McCaughan, G., Schlitt, H., Bishop, A., Bowen, D., Bertolino, P. (2007). The liver: a special case in transplantation tolerance. Seminars in Liver Disease, 27(2), 194-213. [More Information]
  • Shackel, N., McCaughan, G. (2007). Treatment for Cirrhosis-Associated Hyponatremia? Vaptans and Aquaresis. Hepatology, 45, 1080-1081. [More Information]
  • Huang, X., McCaughan, G., Shackel, N., Gorrell, M. (2007). Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis. Liver International, 27(7), 960-968. [More Information]
  • Sadeghi, A., Xiao, C., Sharland, A., Allen, R., McCaughan, G., Bishop, A. (2006). Cytokine common gamma chain expression and its relation to liver transplant tolerance and rejection in a rat model. Immunology and Cell Biology, 84(1), A30-A30.
  • Heyman, J., Whitfield, C., Brock, K., McCaughan, G., Donaghy, A. (2006). Dietary protein intakes in patients with hepatitic encephalopathy and cirrhosis: current practice in NSW and ACT. Medical Journal of Australia, 185(10), 542-543. [More Information]
  • Yu, M., Wang, X., Ajami, K., McCaughan, G., Gorrell, M. (2006). DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis. Advances in Experimental Medicine and Biology, 575, 63-72. [More Information]
  • Wang, C., Cordoba, S., Bertolino, P., Alexander, S., Wu, M., Allen, R., McCaughan, G., Bishop, A. (2006). Examination of the immune mechanism of spontaneous tolerance of renal allografts in a mouse model. Immunology and Cell Biology, 84(1), A29-30.
  • Wang, X., Yu, M., McCaughan, G., Gorrell, M. (2006). Extra-enzymatic roles of DPIV and FAP in cell adhesion and migration on collagen and fibronectin. Advances in Experimental Medicine and Biology, 575, 213-222. [More Information]
  • Yu, M., Wang, X., McCaughan, G., Gorrell, M. (2006). Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. The FEBS Journal, 273(11), 2447-2460. [More Information]
  • Cordoba, S., Wang, C., Williams, R., Li, J., Smit, L., Sharland, A., Allen, R., McCaughan, G., Bishop, A. (2006). Gene array analysis of a rat model of liver transplant tolerance identifies increased complement C3 and the STAT-1/IRF-1 pathway during tolerance induction. Liver Transplantation, 12(4), 636-643. [More Information]
  • Loss, M., Ng, W., Karim, R., Strasser, S., Koorey, D., Gallagher, P., Verran, D., McCaughan, G. (2006). Hereditary lysozyme amyloidosis: Spontaneous hepatic rupture (15 years apart) in mother and daughter. Role of emeregency liver transplantation. Liver Transplantation, 12(7), 1152-1155. [More Information]
  • Dahlke, M., Loi, R., Warren, A., Holz, L., Popp, F., Weiss, D., Piso, P., Bowen, D., McCaughan, G., Schlitt, H., Bertolino, P. (2006). Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cells. Journal of Hepatology, 44(2), 334-341. [More Information]
  • Lam, V., Laurence, J., Sharland, A., McCaughan, G., Hodgkinson, S., Hall, B., Allen, R., Bishop, A. (2006). Induction of long-term cardiac allograft survival using anti-lymphocyte antibodies in the rat model. Immunology and Cell Biology, 84(1), A27-A27.
  • Seth, D., Gorrell, M., Cordoba, S., McCaughan, G., Haber, P. (2006). Intrahepatic gene expression in human alcoholic hepatitis. Journal of Hepatology, 45(2), 306-320. [More Information]
  • Cua, I., Hui, J., Bandara, P., Kench, J., McCaughan, G., George, J. (2006). Is insulin resistance and liver injury in chronic hepatitis C associated with virus-specific alteration in the levels of serum adipocytokines? Journal of Gastroenterology and Hepatology, 21, A22-A22.
  • St George, A., Johnston, A., Bauman, A., Iverson, D., Tapsell, L., McCaughan, G., Strasser, S., McGrath, L., Green, J., Farrell, G., George, J. (2006). Lifestyle intervention in early liver disease: metabolic changes at 3 months. Journal of Gastroenterology and Hepatology, 21(Suppl. 4), A315.
  • Prakoso, E., Strasser, S., Koorey, D., Verran, D., McCaughan, G. (2006). Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation, 20(3), 369-373. [More Information]
  • Bertolino, P., McCaughan, G., Le Couteur, D., Warren, A., Fraser, R., Benseler, V. (2006). Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. Journal of Hepatology, 46, 239-246. [More Information]
  • Benseler, V., Cordoba, S., Wang, C., Zvolynska, A., Sharland, A., Shlitt, H., McCaughan, G., Allen, R., Bishop, A. (2006). Microarray analysis of spontaneously tolerant compared to rejecting rat liver allografts. Immunology and Cell Biology, 84(1), A31-A32.
  • Chen, T., Ajami, K., McCaughan, G., Gai, W., Gorrell, M., Abbott, C. (2006). Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activity. BBA - Bioenergetics, 1764 (1), 33-43. [More Information]
  • Seth, D., Beard, M., Gorrell, M., McCaughan, G., Haber, P. (2006). Osteopontin: An early marker for alcoholic liver injury? Alcoholism: Clinical and Experimental Research, 30(s2), 89A-89A.
  • Kelly, M., Chick, J., Gribble, R., Gleeson, M., Holton, M., Winstanley, J., McCaughan, G., Haber, P. (2006). Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol and Alcoholism, 41(3), 278-283.
  • Buchanan, A., Wang, C., Tran, G., Hodgkinson, S., Hall, B., McCaughan, G., Allen, R., Bishop, A. (2006). Role of IL-4 in rat liver allograft rejection. Immunology and Cell Biology, 84(1 Supplement), A28-A28.
  • Kubitskiy, A., Lanzetta, M., Owen, E., McCaughan, G., Bishop, A. (2006). Simultaneous vascularised bone marrow transplantation to promote acceptance of hind limb allografts. Immunology and Cell Biology, 84(Supplement 1), A30-A30.
  • Gorrell, M., Wang, X., Park, J., Ajami, K., Yu, M., Knott, H., Seth, D., McCaughan, G. (2006). Structure and function in dipeptidyl peptidase IV and related proteins. Advances in Experimental Medicine and Biology, 575, 45-54. [More Information]
  • Warren, A., Le Couteur, D., Fraser, R., Bowen, D., McCaughan, G., Bertolino, P. (2006). T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology, 44(5), 1182-1190. [More Information]
  • Shackel, N., Seth, D., Haber, P., Gorrell, M., McCaughan, G. (2006). The hepatic transcriptome in human liver disease. Comparative Hepatology, 5, 6-6. [More Information]
  • Cordoba, S., Wang, C., Sharland, A., McCaughan, G., Allen, R., Bishop, A. (2006). Transcriptomics of tolerant and rejecting renal allografts. Immunology and Cell Biology, 84(1), A2-A2.
  • Crawford, B., Labio, E., Strasser, S., McCaughan, G. (2006). Vitamin D replacement for cirrhosis-related bone disease. Nature Clinical Practice Gastroenterology and Hepatology, 3(12), 689-699. [More Information]
  • Crawford, B., Kam, C., Pavlovic, J., Byth Wilson, K., Handelsman, D., Angus, P., McCaughan, G. (2006). Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 144(4), 239-248. [More Information]
  • Bandara, P., George, J., McCaughan, G., Naidoo, D., Lux, O., Salonikas, C., Kench, J., Byth Wilson, K., Farrell, G. (2005). Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C. Liver International, 25(3), 518-526. [More Information]
  • Perry, J., Poustchi, H., George, J., Farrell, G., McCaughan, G., Strasser, S. (2005). Current approaches to the diagnosis and management of hepatocellular carcinoma. Clinical and Experimental Medicine, 5(1), 1-13. [More Information]
  • Geier, M., Tenikoff, D., Yazbeck, R., McCaughan, G., Abbott, C., Howarth, G. (2005). Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV. Journal of Cellular Physiology, 204(2), 687-692. [More Information]
  • Benseler, V., Bishop, A., Chng, K., Watson, J., Wang, C., Dahlke, M., Koutalistras, N., Watts, A., Hawthorne, W., McKenzie, P., Hennessy, A., Pleass, H., Chadban, S., Schlitt, H., McCaughan, G., et al (2005). Development of a primate model to evaluate strategies to achieve long term renal allograft acceptance. Immunology and Cell Biology, 83(4 Suppl.), A26-A26.
  • Kanatani, T., Lanzetta, M., Owen, E., Matsumoto, T., Fujioka, H., Kurosaka, M., McCaughan, G., Bishop, A. (2005). Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. Transplantation Proceedings, 37(5), 2382-2384. [More Information]
  • Bertolino, P., Schrage, A., Bowen, D., Klugewitz, K., Ghani, S., Eulenburg, K., Holz, L., Hogg, N., McCaughan, G., Hamann, A. (2005). Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice. Hepatology, 42(5), 1063-1071. [More Information]
  • Cordoba, S., Wang, C., Li, J., Bertolino, P., McCaughan, G., Bishop, A. (2005). Examination of immune mechanisms in a mouse model of spontaneous renal allograft acceptance. Immunology and Cell Biology, 83(4 Supplement), A20-A21.
  • Wang, X., Yu, M., McCaughan, G., Gorrell, M. (2005). Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology, 42(4), 935-945. [More Information]
  • Adams, L., Bulsara, M., Rossi, E., DeBoer, B., Speers, D., George, J., Kench, J., Farrell, G., McCaughan, G., Jeffrey, G. (2005). Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clinical Chemistry (Washington, DC), 51(10), 1867-1873. [More Information]
  • Bowen, D., McCaughan, G., Bertolino, P. (2005). Intrahepatic immunity: a tale of two sites? Trends in Immunology, 26(10), 512-517. [More Information]
  • McCaughan, G., Koorey, D., Strasser, S. (2005). Liver transplantation for viral hepatitis. British Journal of Hospital Medicine (London), 66(1), 8-12. [More Information]
  • Tanaka, H., Verran, D., Shun, A., Dorney, S., Stormon, M., Fisher, J., McCaughan, G. (2005). Liver transplantation utilizing pediatric cadaver donor livers. Pediatric Transplantation, 9(1), 47-51. [More Information]
  • Cordoba, S., Wang, C., Williams, R., Sharland, A., McCaughan, G., Bishop, A. (2005). Meta-analysis of transcriptional profiles in three models of transplant tolerance identifies the STAT-1/IRF-1 pathway. Immunology and Cell Biology, 83(4), A31-A31.
  • Sun, J., Tumurbaatar, B., Jia, J., Diao, H., Bodola, F., Lemon, S., Tang, W., Bowen, D., McCaughan, G., Bertolino, P., et al (2005). Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury. Journal of Virology, 79(16), 10730-10739. [More Information]
  • Holz, L., Benseler, V., Gengos, M., Newtown, R., McCaughan, G., Bertolino, P. (2005). Phenotype of CD8+ T cells activated in the liver. Tissue Antigens: immune response genetics, 66(5), 444 (Abstract 279)-444.
  • Zahir, H., McLachlan, A., Nelson, A., McCaughan, G., Gleeson, M., Akhlaghi, F. (2005). Population Pharmacokinetic Estimation of Tacrolimus Apparent Clearance in Adult Liver Transplant Recipients. Therapeutic Drug Monitoring, 27(4), 422-430. [More Information]
  • Wang, C., Li, J., Cordoba, S., McLeod, D., Tran, G., Hodgkinson, S., Hall, B., McCaughan, G., Bishop, A. (2005). Posttransplant Interleukin-4 Treatment Converts Rat Liver Allograft Tolerance to Rejection. Transplantation, 79(9), 1116-1120. [More Information]
  • Wang, C., Li, J., Tran, G., Hodgkinson, S., Hall, B., McCaughan, G., Allen, R., Bishop, A. (2005). Role of IL-4 in rat liver allograft rejection. Immunology and Cell Biology, 83(4 Supplement), A11-A11.
  • Benseler, V., Warren, A., Holz, L., Gengos, M., Bowen, D., Le Couteur, D., Schlitt, H., McCaughan, G., Bertolino, P. (2005). The liver promotes antigen-specific retention and rapid clearance of naive CD8(+) T cells activated in situ. Tissue Antigens: immune response genetics, 66(5), 359-360.
  • Cordoba, S., Wang, C., Williams, R., Sharland, A., Allen, R., McCaughan, G., Bishop, A. (2005). The STAT-1/IRF-1 signalling pathway and complement cascade are increased in rat liver transplant tolerance identified by meta-analysis of high-throughput screening techniques. Hepatology, 42(4 S1), 314A-314A.
  • Zekry, A., Gleeson, M., Guney, S., McCaughan, G. (2004). A Prospective Cross-Over Study Comparing The Effect Of Mycophenolate Versus Azathioprine On Allograft Function And Viral Load In Liver Transplant Recipients With Recurrent Chronic Hcv Infection. Liver Transplantation, 10(1), 52-57. [More Information]
  • Zahir, H., McCaughan, G., Gleeson, M., Nand, R., McLachlan, A. (2004). Changes In Tacrolimus Distribution In Blood And Plasma Protein Binding Following Liver Transplantation. Therapeutic Drug Monitoring, 26(5), 506-515.
  • Den Dulk, M., Wang, C., Li, J., Clark, D., Hibberd, A., Terpstra, O., McCaughan, G., Bishop, A. (2004). Combined Donor Leucocyte Administration And Immunosuppressive Drug Treatment For Survival Of Rat Heart Allografts. Transplant Immunology, 13(3), 177-184.
  • Ajami, K., Abbott, C., McCaughan, G., Gorrell, M. (2004). Dipeptidyl Peptidase 9 Has Two Forms, A Broad Tissue Distribution, Cytoplasmic Localization And DPIV-Like Peptidase Activity. BBA - Bioenergetics, 1679 (1), 18-28. [More Information]
  • Kanatani, T., Wright, B., Lanzetta, M., Molitor, M., McCaughan, G., Bishop, A. (2004). Experimental Limb Transplantation, Part III: Induction Of Tolerance In The Rigorous Strain Combination Of Brown Norway Donor To Lewis Recipient. Transplantation Proceedings, 36(10), 3276-3282.
  • Zahir, H., McCaughan, G., Gleeson, M., Nand, R., McLachlan, A. (2004). Factors Affecting Variability In Distribution Of Tacrolimus In Liver Transplant Recipients. British Journal of Clinical Pharmacology, 57(3), 298-309.
  • McCaughan, G., George, J. (2004). Fibrosis Progression In Chronic Hepatitis C Virus Infection. Gut (English Edition): an international journal of gastroenterology and hepatology, 53(3), 318-321.
  • Sud, A., Hui, J., Farrell, G., Bandara, P., Kench, J., Fung, C., Lin, R., Samarasinghe, D., Liddle, C., McCaughan, G., George, J. (2004). Improved Prediction Of Fibrosis In Chronic Hepatitis C Using Measures Of Insulin Resistance In A Probability Index. Hepatology, 39(5), 1239-1247. [More Information]
  • Jonsson, J., Gu, W., Vanags, D., Bishop, A., McCaughan, G., Fawcett, J., Lynch, S., Balderson, G., Powell, E., Clouston, A. (2004). Increased Mononuclear Cell Activation And Apoptosis Early After Human Liver Transplantation Is Associated With A Reduced Frequency Of Acute Rejection. Liver Transplantation, 10(3), 397-403. [More Information]
  • McCaughan, G., Zekry, A. (2004). Mechanisms Of Hcv Reinfection And Allograft Damage After Liver Transplantation. Journal of Hepatology, 40(3), 368-374. [More Information]
  • Crawford, D., Fletcher, L., Hubscher, S., Stuart, K., Gane, E., Angus, P., Jeffrey, G., McCaughan, G., Kerlin, P., Powell, L., et al (2004). Patient And Graft Survival After Liver Transplantation For Hereditary Hemochromatosis: Implications For Pathogenesis. Hepatology, 39(6), 1655-1662. [More Information]
  • McCaughan, G., Bertolino, P., Bowen, D., Zen, M., Holz, L., Davis, T. (2004). The Site Of Primary T Cell Activation Is A Determinant Of The Balance Between Intrahepatic Tolerance And Immunity. Journal of Clinical Investigation, 114(5), 701-712.
  • McDougall, A., Davies, L., McCaughan, G. (2003). Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle and Nerve, 28(5), 595-600. [More Information]
  • Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., McCaughan, G. (2003). Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplantation, 9(5), 500-505.
  • Seth, D., Leo, M., McGuinness, P., Lieber, C., Brennan, Y., Williams, R., Wang, X., McCaughan, G., Gorrell, M., Haber, P. (2003). Gene expression profiling of alcoholic liver disease in the Baboon (Papio hamadryas) and human liver. The American Journal of Pathology: cellular and molecular biology of disease, 163(6), 2303-2317.
  • McCaughan, G., Zekry, A. (2003). Impact of immunosuppression on immunopathogenesis of liver damage in Hepatitis C virus-infected recipients following liver transplantation. Liver Transplantation, 9(11), S21-S27.
  • Hui, J., Sud, A., Farrell, G., Bandara, P., Byth Wilson, K., Kench, J., McCaughan, G., George, J. (2003). Insulin resistance is associated with chronic Hepatitis C and virus infection fibrosis progression. Gastroenterology, 125(6), 1695-1704.
  • Shackel, N., McGuiness, P., Abbott, C., Gorrell, M., McCaughan, G. (2003). Novel differential gene expression in human cirrhosis detected by suppression substractive hybridization. Hepatology, 38(3), 577-588.
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive Transfer of Nut Allergy After Liver Transplantation. Archives of Internal Medicine, 163(2), 237-239.
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive transfer of nut allergy after liver transplantation. Archives of Internal Medicine, 163(2), 237-239.
  • Haber, P., Warner, R., Seth, D., Gorrell, M., McCaughan, G. (2003). Pathogenesis and management of alcoholic hepatitis. Journal of Gastroenterology and Hepatology, 18(12), 1332-1344.
  • Perry, J., Strasser, S., George, J., Farrell, G., McCaughan, G. (2003). Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy, 4(12), 2175-2185.
  • Seth, D., Gorrell, M., McGuiness, P., Leo, M., Lieber, C., McCaughan, G., Haber, P. (2003). SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. Journal Of Biochemical and Biophysical Methods, 55(1), 53-66.
  • Ajami, K., Abbott, C., Obradovic, M., Gysbers, V., Kahne, T., McCaughan, G., Gorrell, M. (2003). Structural requirements for catalysis, expression, dimerization in the CD26/DPIV gene family. Biochemistry, 42(3), 694-701.
  • Crawford, B., Kam, C., Donaghy, A., McCaughan, G. (2003). The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporosis International, 14(12), 987-994. [More Information]
  • Bowen, D., Warren, A., Davis, T., Hoffmann, M., McCaughan, G., Fazekas, B., Bertolino, P. (2002). Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8+ T-cell activation by bone marrow-derived cells. Gastroenterology, 123(4), 1252-1264.
  • Yin, J., Pilmore, H., Yan, Y., McCaughan, G., Bishop, A., Hambly, B., Eris, J. (2002). Expression of growth arrest-specific gene 6 and its receptors in a rat model of chronic renal transplant rejection. Transplantation, 73(4), 657-660.
  • Shackel, N., Gorrell, M., McCaughan, G. (2002). Gene array analysis and the liver. Hepatology, 36(6), 1313-1325.
  • McCaughan, G., Koorey, D., Strasser, S. (2002). Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal, 32(8), 394-400.
  • Shackel, N., McGuinness, P., Abbott, C., Gorrell, M., McCaughan, G. (2002). Insights into the pathobiology of hepatitis C virus-associated cirrhosis. The American Journal of Pathology: cellular and molecular biology of disease, 160(2), 641-654.
  • Zekry, A., Bishop, A., Bowen, D., Gleeson, M., Guney, S., Painter, D., McCaughan, G. (2002). Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transplantation, 8(3), 292-301.
  • Levy, M., McCaughan, G., Marinos, G., Gorrell, M. (2002). Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver International, 22(2), 93-101.
  • McCaughan, G., Zekry, A. (2002). Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transplantation, 8(10B), S7-S13.
  • Yan, Y., Putten, K., Bowen, D., Painter, D., Kohar, J., Sharland, A., McCaughan, G., Bishop, A. (2002). Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with TH2 cytokine expression in long-term accepted grafts. Transplantation, 73(7), 1123-1130.
  • McDougall, A., Davies, L., McCaughan, G. (2002). Rapid improvement of autonomic and peripheral neuropathy after liver transplantation: a single case report. Liver Transplantation, 8(2), 164-166.
  • Bertolino, P., McCaughan, G., Bowen, D. (2002). Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'. Immunology and Cell Biology, 80(1), 84-92.
  • Bishop, A., Wang, C., Sharland, A., McCaughan, G. (2002). Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect. Immunology and Cell Biology, 80(1), 93-100.
  • Pilmore, H., Yan, Y., Eris, J., Hennessy, A., McCaughan, G., Bishop, A. (2002). Time course of upregulation of fibrogenic growth factors and cellular infiltration in a rodent model of chronic renal allograft rejection. Transplant Immunology, 10(4), 245-254.
  • McCaughan, G. (2002). Withdrawal of immunosuppression in liver transplant recipients: is this as good as it gets. Liver Transplantation, 8(4), 408-410.
  • Wang, C., Sun, J., Sheil, A., McCaughan, G., Bishop, A. (2001). A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation, 72(1), 44-51.
  • Haber, P., Nakamura, M., Tsuchimoto, K., Ishii, H., Keogh, G., Apte, M., Moran, C., Stewart, N., Crawford, D., Pirola, R., McCaughan, G., Ramm, G., Conigrave, K., et al (2001). Alcohol and the pancreas. Alcoholism: Clinical and Experimental Research, 25, 244S-250S.
  • Bertolino, P., Bowen, D., McCaughan, G., Fazekas, B. (2001). Antigen-Specific Primary Activation of CD8(+) T Cells Within the Liver. Journal of Immunology, 166, 5430-5438.
  • Shackel, N., McGuinness, P., Abbott, C., Gorell, M., McCaughan, G. (2001). Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut (English Edition): an international journal of gastroenterology and hepatology, 49, 565-576.
  • Bishop, A., McCaughan, G. (2001). Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy. Liver Transplantation, 7(3), 161-172.
  • Verran, D., Gurkan, A., Dilworth,, P., Painter, D., Chui,, A., Dorney, S., Shun, A., Koorey, D., McCaughan, G., Sheil, A. (2001). Inferior liver allograft survival from cadaveric donors > 50 years of age? Clinical Transplantation, 15(2), 106-110.
  • Koorey, D., McCaughan, G., Sheil, A., Verran, D., Gurka, J., Dilworth,, P., Painter, D., Chui,, A., Dorney, S., Shun, A. (2001). Inferior liver allograft survivial from cadaveric donors: > 50 years of age? Clinical Transplantation, 15, 106-110.
  • Yan, Y., Shastry, S., Richards, C., Wang, C., Bowen, D., Sharland, A., Painter, D., McCaughan, G., Bishop, A. (2001). Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. Journal of Immunology, 166, 5258-5264.
  • Yin, J., Shackel, N., Zekry, A., McGuinness, P., Richards, C., van der Putten, K., McCaughan, G., Eris, J., Bishop, A. (2001). Real-time reverse transcriptases-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green 1. Immunology and Cell Biology, 79(3), 213-221.
  • Doran, T., Geczy, A., Painter, D., McCaughan, G., Sheil, A., Susal, C., Opelz, G. (2000). A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation, 69(7), 1491-1498.
  • Chui, A., Shi, L., Rao, A., Verran, D., Painter, D., Koorey, D., McCaughan, G., Sheil, A. (2000). Donor Fatty (Steatotic) Liver Allografts in Orthotopic Liver Transplantation: A Revisit. Transplantation Proceedings, 32(7), 2101-2102.
  • Pilmore, H., Painter, D., Bishop, A., McCaughan, G., Eris, J. (2000). Early up-regulation of macrophages and myofibroblasts. Transplantation, 69(12), 2658-2662.
  • Latt, N., Spencer, D., Beeby, P., McCaughan, G., Saunders, J., Collins,, E., Cossart, Y. (2000). Hepatitis C in injecting drug-using women during and after pregnancy. Journal of Gastroenterology and Hepatology, 15, 175-181.
  • Chui, A., Rao, A., Waugh, R., Mayr, M., Verran, D., Koorey, D., McCaughan, G., Ong, J., Sheil, A. (2000). Liver transplantation in patients with transjugular intrahepatic portosystemic shunts. ANZ Journal of Surgery, 70(7), 493-495.
  • McCaughan, G., Gorrell, M., Bishop, A., Abbott, C., Shackel, N., McGuinness, P., Levy, M., Sharland, A., Bowen, D., Yu, M., Slaitini, L., Napoli, J., et al (2000). Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunological Reviews, 174(1), 172-191.
  • Rao, A., Chui, A., Gurkan, A., Shi, L., Al-harbi, I., Waugh, R., Verran, D., McCaughan, G., Koorey, D., Sheil, A. (2000). Orthotopic Liver Transplantation for Treatment of Patients With Budd–Chiari Syndrome: A Singe-Center Experience. Transplantation Proceedings, 32(7), 2206-2207.
  • Verran, D., Gurkan, A., Chui, A., Dilworth,, P., Koorey, D., McCaughan, G., Sheil, A. (2000). Pancreatitis in adult orthotopic liver allograft recipients: risk factors and outcome. Liver Transplantation, 6, 632-366.
  • Chui, A., Shi, L., Rao, A., Anasuya, A., Hagi, C., Pillay, P., Verran, D., McCaughan, G., Sheil, A. (2000). Primary Graft Dysfunction After Liver Transplantation. Transplantation Proceedings, 32(7), 2219-2220.

Conferences

  • Haber, P., McCaughan, G., Shaw, D., Matthews, G., Hellard, M., Dore, G., Lloyd, A., Kaldor, J., Rowlinson, W., Ffrench, R. (2007). Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the australian trial in acute hepatitis C (ATAHC). The 58th Annual Meeting of the American Association for the Study of Liver Diseases, United States of America: John Wiley & Sons.
  • Benseler, V., Holz, L., Schlitt, H., Brinkmann, V., McCaughan, G., Bertolino, P. (2006). FTY720 treatment leads to sequestration but not accumulation of antigen-specific CD8+ T cells activated in lymph nodes.
  • Seth, D., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2006). Identification of novel therapeutic targets for alcoholic liver disease. International Society for Biomedical Research on Alcoholism World congress on Alcohol Research (ISBRA 2006), Maryland: Wiley-Blackwell Publishing.
  • Wang, X., Yu, D., Schnapp, A., Marguet, D., Cordoba, S., Retting, W., McCaughan, G., Gorrell, M. (2005). The role of fibroblast activation protein (FAP) in cell adhesion, migration and liver fibrosis. 56th Annual Meeting of the American Association for the Study of Liver Diseases, United States: John Wiley & Sons.

2014

  • Shackel, N., Vadas, M., Gamble, J., McCaughan, G. (2014). Beyond Liver Fibrosis: Hepatic Stellate Cell Senescence Links Obesity to Liver Cancer by Way of the Microbiome. Hepatology, 59(6), 2413-2415. [More Information]
  • Roberts, S., Mitchell, J., Leung, R., Booth, D., Bollipo, S., Ostapowicz, G., Sloss, A., McCaughan, G., Dore, G., Thompson, A., George, J., et al (2014). Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies. Journal of Gastroenterology and Hepatology, 29(1), 179-184. [More Information]
  • Keane, F., Tsun-Wen, Y., Seelk, S., Gall, M., Chowdhury, S., Poplawski, S., Lai, J., Li, Y., Wu, W., Farrell, P., Vieira de Ribeiro, A., Osborne, B., Yu, M., Seth, D., Haber, P., Wang, C., Thomson, S., Twigg, S., McLennan, S., McCaughan, G., Gorrell, M., et al (2014). Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio, 4, 43-54. [More Information]
  • Grzelak, C., Martelotto, L., Sigglekow, N., Patkunanathan, B., Ajami, K., Calabro, S., Dwyer, B., Tirnitz-Parker, J., Watkins, D., Warner, F., Shackel, N., McCaughan, G. (2014). The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. Journal of Hepatology, 60(1), 143-151. [More Information]

2013

  • Tu, T., Shackel, N., McCaughan, G. (2013). "Testing your methyl": DNA methylation profiling of serum DNA of HCC patients. Hepatology International, 7(3), 785-787. [More Information]
  • Bendorf, A., Kelly, P., Kerridge, I., McCaughan, G., Myerson, B., Stewart, C., Pussell, B. (2013). An International Comparison of the Effect of Policy Shifts to Organ Donation following Cardiocirculatory Death (DCD) on Donation Rates after Brain Death (DBD) and Transplantation Rates. PLoS One, 8(5), 1-7. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Author reply: RE Terlipressin therapy for moderate to severe hyponatraemia in patients with liver failure. Internal Medicine Journal, 43(5), 607-607. [More Information]
  • Gane, E., Patterson, S., Strasser, S., McCaughan, G., Angus, P. (2013). Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transplantation, 19(3), 268-274. [More Information]
  • Na, R., Grulich, A., Meagher, N., McCaughan, G., Keogh, A., Vajdic, C. (2013). Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients. American Journal of Transplantation, 13(1), 174-183. [More Information]
  • McCaughan, G. (2013). Current Management of HBV Pre and Post Liver Transplant. Current Hepatitis Reports, 12(2), 119-123. [More Information]
  • Na, R., Grulich, A., Meagher, N., McCaughan, G., Keogh, A., Vajdic, C. (2013). De novo Cancer-Related Death in Australian Liver and Cardiothoracic Transplant Recipients. American Journal of Transplantation, 13(5), 1296-1304. [More Information]
  • McCaughan, G., Vajdic, C. (2013). De novo malignant disease after liver transplantation? Risk and surveillance strategies. Liver Transplantation, 19(Suppl. 2), S62-S67. [More Information]
  • Tay, S., Lu, B., Sierro, F., Benseler, V., McGuffog, C., Bishop, A., Cowan, P., McCaughan, G., Dwyer, K., Bowen, D., et al (2013). Differential migration of passenger leukocytes and rapid deletion of naive alloreactive CD8 T cells after mouse liver transplantation. Liver Transplantation, 19(11), 1224-1235. [More Information]
  • McCaughan, G. (2013). Early hepatocellular carcinoma - is there such a thing as too early? Journal of Hepatology, 58(2), 210-211. [More Information]
  • Cunningham, E., Tay, S., Wang, C., Rtshiladze, M., Wang, Z., McGuffog, C., Cubitt, J., McCaughan, G., Alexander, I., Bertolino, P., Sharland, A., Bowen, D., Bishop, A. (2013). Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts. Transplantation, 95(1), 70-77. [More Information]
  • Berenguer, M., McCaughan, G. (2013). Hepatitis C virus-associated cholestatic hepatitis: We cannot seem to agree on diagnostic criteria. Liver Transplantation, 19(2), 115-117. [More Information]
  • Verran, D., Mulheam, M., Dilworth, P., Balderson, G., Munn, S., Chen, J., Fink, M., Crawford, M., McCaughan, G. (2013). Nature and outcomes of the increased incidence of colorectal malignancy after liver transplantation in Australasia. Medical Journal of Australia, 199(9), 610-612. [More Information]
  • McCaughan, G., Bowen, D., Bertolino, P. (2013). Operational tolerance in liver transplantation: Shall we predict or promote? Liver Transplantation, 19(9), 933-936. [More Information]
  • Saunderson, R., Garsia, R., Headley, A., McCaughan, G., O'Toole, S., Strasser, S. (2013). Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. Journal of Dermatological Case Reports, 7(3), 77-81. [More Information]
  • Chowdhury, S., Chen, Y., Yao, T., Ajami, K., Wang, X., Popov, Y., Schuppan, D., Bertolino, P., McCaughan, G., Yu, M., Gorrell, M. (2013). Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. World Journal of Gastroenterology, 19(19), 2883-2893. [More Information]
  • Young, J., Ting, K., Li, J., Moller, T., Dunn, L., Lu, Y., Moses, J., Prado-Lourenco, L., Khachigian, L., Ng, M., Lichtenstein, I., Tran, N., Shackel, N., Kench, J., McCaughan, G., Vadas, M., Gamble, J., et al (2013). Regulation of vascular leak and recovery from ischaemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood, 122(16), 2911-2919. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Terlipressin Therapy for Moderate to Severe Hyponatremia in Patients with Liver Failure. Internal Medicine Journal, 43(3), 240-246. [More Information]
  • Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]
  • Kitson, M., Dore, G., George, J., Button, P., McCaughan, G., Crawford, D., Sievert, W., Weltman, M., Cheng, W., Roberts, S. (2013). Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology, 58(3), 467-472. [More Information]

2012

  • Lau, E., McCaughan, G., Torzillo, P. (2012). A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations. Internal Medicine Journal, 42(5), 600-601. [More Information]
  • Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012). Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International, 32(10), 1527-1534. [More Information]
  • Omata, M., Kanda, T., Yu, M., Yokosuka, O., Lim, S., Jafri, W., Tateishi, R., Hamid, S., Chuang, W., Chuttaputti, A., McCaughan, G., et al (2012). APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatology International, 6(2), 409-435. [More Information]
  • McCaughan, G., Vajdic, C., Grulich, A. (2012). Cancer risk after organ transplantation. JAMA, 307(7), 663; author reply 663-664. [More Information]
  • Ganbold, A., Andersen, S., Tay, S., Cunningham, E., Ilie, V., Krishnan, S., Wang, C., McCaughan, G., Sharland, A., Bishop, A. (2012). Expression of common gamma chain signalling cytokines and their receptors distinguishes rejection from tolerance in a rat organ transplant model. Transplant Immunology, 27(2-3), 89-94. [More Information]
  • Graaf, E., Kench, J., Dilworth, P., Shackel, N., Strasser, S., Joseph, D., Pleass, H., Crawford, M., McCaughan, G., Verran, D. (2012). Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. Journal of Gastroenterology and Hepatology, 27(3), 540-546. [More Information]
  • McCaughan, G. (2012). Is the end of chronic hepatitis C virus infection in sight? Medical Journal of Australia, 196(10), 614-614. [More Information]
  • Holz, L., Benseler, V., Vo, M., McGuffog, C., Van Rooijen, N., McCaughan, G., Bowen, D., Bertolino, P. (2012). Naive CD8 T cell activation by liver bone marrow-derived cells leads to a "neglected" IL-2(low) Bim(high) phenotype, poor CTL function and cell death. Journal of Hepatology, 57(4), 830-836. [More Information]
  • Thompson, A., McHutchison, J., McCaughan, G. (2012). New Horizons: IL28, Direct-acting Antiviral Therapy for HCV. In Geoffrey W. McCaughan, John G. McHutchison, Jean-Michel Pawlotsky (Eds.), Advanced Therapy for Hepatitis C, (pp. 196-213). Chichester, United Kingdom: Wiley-Blackwell Publishing.
  • McCaughan, G. (2012). New therapies against HCV: Expected risks and challenges associated with their use in the liver transplant setting. Journal of Hepatology, 57(6), 1361-1367. [More Information]
  • Keane, F., Chowdhury, S., Yao, T., Nadvi, N., Gall, M., Chen, Y., Osborne, B., Ribeiro, A., Church, W., McCaughan, G., Gorrell, M., Yu, M. (2012). Targeting Dipeptidyl Peptidase-4 (DPP-4) and Fibroblast Activation Protein (FAP) for Diabetes and Cancer Therapy. In Ben Dunn (Eds.), Proteinases as Drug Targets, (pp. 118-144). Cambridge, UK: RSC Publishing.
  • Bishop, A., Bertolino, P., Bowen, D., McCaughan, G. (2012). Tolerance in liver transplantation. Best Practice & Research: Clinical Gastroenterology, 26(1), 73-84. [More Information]
  • McCaughan, G. (2012). Trekking new ground: Overcoming medical and social impediments for extended criteria liver transplant recipients. Liver Transplantation, 18(11 Supp 2 (November)), S39-S46. [More Information]
  • Barbier, L., Tay, S., McGuffog, C., Triccas, J., McCaughan, G., Bowen, D., Bertolino, P. (2012). Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. Journal of Hepatology, 57(2), 352-358. [More Information]

2011

  • Yao, T., Kim, W., Yu, D., Sharbeen, G., McCaughan, G., Choi, K., Xia, P., Gorrell, M. (2011). A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling. Molecular Cancer Research, 9(7), 948-959. [More Information]
  • Sievert, W., Altraif, I., Razavi, H., Abdo, A., Ahmed, E., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., McCaughan, G., et al (2011). A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver International, 31(Suppl 2), 61-80. [More Information]
  • Bishop, A., Ierino, F., Sharland, A., Hall, B., Alexander, S., Sandrin, M., Coates, P., McCaughan, G. (2011). Approaching the promise of operational tolerance in clinical transplantation. Transplantation, 91(10), 1065-1074. [More Information]
  • Lo, L., McLennan, S., Williams, P., Bonner, J., Chowdhury, S., McCaughan, G., Gorrell, M., Yue, D., Twigg, S. (2011). Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. Journal of Hepatology, 55(2), 435-444. [More Information]
  • Song, S., Shackel, N., Wang, X., Ajami, K., McCaughan, G., Gorrell, M. (2011). Discoidin Domain Receptor 1: Isoform expression and potential functions in cirrhotic human liver. The American Journal of Pathology: cellular and molecular biology of disease, 178(3), 1134-1144. [More Information]
  • Baleriola, C., Rawlinson, W., Dore, G., Chaverot, S., Stelzer-Braid, S., Yoshihara, M., Crawford, D., Sievert, W., McCaughan, G., Weltman, M., et al (2011). Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients. Antiviral Therapy, 16(2), 173-180. [More Information]
  • Poustchi, H., Farrell, G., Strasser, S., Lee, A., McCaughan, G., George, J. (2011). Feasibility of conducting a randomised control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology, 54(6), 1998-2004. [More Information]
  • Benseler, V., Warren, A., Vo, M., Holz, L., Tay, S., Le Couteur, D., Breen, E., Allison, A., Van Rooijen, N., McGuffog, C., Bowen, D., McCaughan, G., Bertolino, P., et al (2011). Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 108(40), 16735-16740. [More Information]
  • McCaughan, G., Shackel, N., Bowen, D. (2011). Liver transplantation and hepatitis C: will understanding the interleukin-28B polymorphisms improve outcomes? Liver Transplantation, 17(3), 219-221. [More Information]
  • Bishop, A., Sharland, A., Ierino, F., Sandrin, M., Hall, B., Alexander, S., Coates, P., McCaughan, G. (2011). Operational Tolerance in Organ Transplantation Versus Tissue Engineering: Into the Future. Transplantation, 92(8), e39-e39. [More Information]
  • McCaughan, G., Bowen, D. (2011). Pathogenesis of cholestatic hepatitis C. Journal of Hepatology, 54, 392-394. [More Information]
  • McCaughan, G. (2011). Prevention of post liver transplant HBV recurrence. Hepatology International, 5(4), 876-881. [More Information]
  • Gamble, J., Vadas, M., McCaughan, G. (2011). Sinusoidal endothelium is essential for liver regeneration. Hepatology, 54(2), 731-733. [More Information]
  • Yu, M., Slaitini, L., Gysbers, V., Riekhoff, A., Kähne, T., Knott, H., De Meester, I., Abbott, C., McCaughan, G., Gorrell, M. (2011). Soluble CD26/Dipeptidyl Peptidase IV Enhances Human Lymphocyte Proliferation In Vitro Independent of Dipeptidyl Peptidase Enzyme Activity and Adenosine Deaminase Binding. Scandinavian Journal of Immunology, 73(2), 102-111. [More Information]
  • Wang, C., Cordoba, S., Hu, M., Bertolino, P., Bowen, D., Sharland, A., Allen, R., Alexander, S., McCaughan, G., Bishop, A. (2011). Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments. Transplant Immunology, 24(3), 149-156. [More Information]
  • Gorrell, M., Zekry, A., McCaughan, G., Lloyd, A. (2011). The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infection. Hepatology, 54(5), 1875-1879. [More Information]

2010

  • Wang, C., Tay, S., Tran, G., Hodgkinson, S., Allen, R., Hall, B., McCaughan, G., Sharland, A., Bishop, A. (2010). Donor IL-4 treatment induces alternatively activated liver macrophages and IDO-Expressing NK cells and promotes rat liver allograft acceptance. Transplant Immunology, 22(3-4), 172-178. [More Information]
  • Dore, G., Hellard, M., Matthews, G., Grebely, J., Haber, P., Petoumenos, K., Yeung, B., Marks, P., van Beek, I., McCaughan, G., et al (2010). Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology, 138(1), 123-135.e1-2. [More Information]
  • Lau, E., McCaughan, G., Torzillo, P. (2010). Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism. Liver Transplantation, 16(7), 870-873. [More Information]
  • Prakoso, E., Verran, D., Dilworth, P., Kyd, G., Tang, P., Tse, C., Koorey, D., Strasser, S., Stormon, M., Shun, A., Allen, R., et al (2010). Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Internal Medicine Journal, 40(9), 619-625. [More Information]
  • Cheng, W., Roberts, S., McCaughan, G., Sievert, W., Weltman, M., Crawford, D., Rawlinson, W., Marks, P., Thommes, J., Rizkalla, B., et al (2010). Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing. Journal of Hepatology, 53(4), 616-623. [More Information]
  • McCaughan, G., Shackel, N., Strasser, S., Dilworth, P., Tang, P. (2010). Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transplantation, 16(2), 130-137. [More Information]
  • McCaughan, G. (2010). Organ donation in Australia. Internal Medicine Journal, 40(8), 603-604. [More Information]
  • Shackel, N., Bowen, D., McCaughan, G. (2010). Snipping away at hepatitis C. Hepatology, 51(2), 703-705. [More Information]
  • Yu, M., Yao, T., Chowdhury, S., Nadvi, N., Osborne, B., Church, W., McCaughan, G., Gorrell, M. (2010). The dipeptidyl peptidase IV family in cancer and cell biology. The FEBS Journal, 277(5), 1126-1144. [More Information]

2009

  • Eckersley-Maslin, M., Grzelak, C., McCaughan, G., Shackel, N. (2009). Bone marrow stem cells and the liver: are they relevant? Journal of Gastroenterology and Hepatology, 24(10), 1608-1616. [More Information]
  • Matthews, G., Hellard, M., Haber, P., Yeung, B., Marks, P., Baker, D., McCaughan, G., Sasadeusz, J., White, P., Rawlinson, W., et al (2009). Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C. Clinical Infectious Diseases, 48(5), 650-658. [More Information]
  • Rauch, A., James, I., Pfafferott, K., Nolan, D., Klenerman, P., Cheng, W., Mollison, L., McCaughan, G., Shackel, N., Jeffrey, G., et al (2009). Diverged Adaptation of Hepatitis C Virus Genotypes 1 and 3 to Human Leukocyte Antigen-Restricted Immune Pressure. Hepatology, 50(4), 1017-1029. [More Information]
  • Sandroussi, C., Crawford, M., Lockwood, D., Tang, P., Gallagher, J., Pleass, H., Strasser, S., Shackel, N., McCaughan, G., Verran, D. (2009). Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients. Liver Transplantation, 15(11), 1586-1593. [More Information]
  • Shackel, N., Jamias, J., Rahman, W., Prakoso, E., Strasser, S., Koorey, D., Crawford, M., Verran, D., Gallagher, J., McCaughan, G. (2009). Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C–Related Liver Failure Post–Liver Transplantation. Liver Transplantation, 15(7), 709-718. [More Information]
  • Laurence, J., McCaughan, G., Logan, G., Alexander, I., Bishop, A., Sharland, A. (2009). Gene therapy in transplantation. Transplantation Reviews, 23(3), 159-170. [More Information]
  • Gaudieri, S., Rauch, A., Pfafferott, K., Barnes, E., McCaughan, G., Shackel, N., Cheng, W., Jeffrey, G., Mollison, L., Baker, R., et al (2009). Hepatitis C Virus Drug Resistance and Immune-Driven Adaptations: Relevance to New Antiviral Therapy. Hepatology, 49(4), 1069-1082. [More Information]
  • Roberts, S., Weltman, M., Crawford, D., McCaughan, G., Sievert, W., Cheng, W., Rawlinson, W., Desmond, P., Marks, P., Yoshihara, M., et al (2009). Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology, 50(4), 1045-1055. [More Information]
  • McCaughan, G., Shackel, N., Bertolino, P., Bowen, D. (2009). Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes. Transplantation, 87(8), 1105-1111. [More Information]
  • Laurence, J., Wang, C., Zheng, M., Cunningham, S., Earl, J., Tay, S., Allen, R., McCaughan, G., Alexander, I., Bishop, A., Sharland, A. (2009). Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transplantation, 15(2), 233-241. [More Information]
  • Bowen, D., Zekry, A., Bertolino, P., Shackel, N., McCaughan, G. (2009). Pathology and pathogenesis of hepatitis C. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 43-75). East Hawthorn, Victoria: IP Communications.
  • Yu, M., Ajami, K., Gall, M., Park, J., Lee, C., Evans, K., McLaughlin, E., Pitman, M., Abbott, C., McCaughan, G., Gorrell, M. (2009). The In Vivo Expression of Dipeptidyl Peptidases 8 and 9. Journal of Histochemistry and Cytochemistry: imaging the spectrum of cell biology, 57(11), 1025-1040. [More Information]
  • Geenen, I., Sosef, M., Shun, A., Crawford, M., Gallagher, J., Strasser, S., Stormon, M., McCaughan, G., Verran, D. (2009). Usage and Outcomes of Deceased Donor Liver Allografts with Preprocurement Injury from Blunt Trauma. Liver Transplantation, 15(3), 321-325. [More Information]

2008

  • Angus, P., Patterson, S., Strasser, S., McCaughan, G., Gane, E. (2008). A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis. Hepatology, 48(5), 1460-1466. [More Information]
  • McCaughan, G. (2008). Adrenal insufficiency and liver disease - Re-search. Journal of Hepatology, 48(6), 1018. [More Information]
  • Laurence, J., Wang, C., Park, E., Buchanan, A., Clouston, A., Allen, R., McCaughan, G., Bishop, A., Sharland, A. (2008). Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection. Transplantation, 85(9), 1357-1361. [More Information]
  • Alghamdi, H., Crawford, M., Gallagher, J., McCaughan, G., Strasser, S., Verran, D. (2008). Cadaveric liver transplant from older donors. Saudi Medical Journal, 29(4), 533-538. [More Information]
  • Devanshi, S., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2008). Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. Journal of Hepatology, 48(4), 614-627. [More Information]
  • Wang, X., Yao, T., Nadvi, N., Osborne, B., McCaughan, G., Gorrell, M. (2008). Fibroblast activation protein and chronic liver disease. Frontiers in Bioscience, 13, 3168-3180. [More Information]
  • Lam, V., Taylor, C., Laurence, J., Wang, C., Sharland, A., McCaughan, G., Hodgkinson, S., Allen, R., Hall, B., Bishop, A. (2008). Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: Effect on foxp3 and cytokine expression and graft infiltration. Transplant Immunology, 19(1), 20-24. [More Information]
  • Shackel, N., McCaughan, G., Warner, F. (2008). Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin-6 signaling. Hepatology, 47(6), 2134-2136. [More Information]
  • Bertolino, P., McCaughan, G., Bowen, D. (2008). Immunological Parameters Influencing Adaptive Immune Responses to the Hepatitis C Virus. In Emilio Jirillo (Eds.), Hepatitis C Virus Disease: Immunobiology and Clinical Applications, (pp. 39-70). United States: Springer.
  • Neuman, M., Sha, K., Esguerra, R., Zakhari, S., Winkler, R., Hilzenrat, N., Wyse, J., Cooper, C., Seth, D., Gorrell, M., Haber, P., McCaughan, G., et al (2008). Inflammation and Repair in Viral Hepatitis C. Digestive diseases and sciences, 53(6), 1468-1487. [More Information]
  • Holz, L., Benseler, V., Bowen, D., Bouillet, P., Strasser, A., O'Reilly, L., D'Avigdor, W., Bishop, A., McCaughan, G., Bertolino, P. (2008). Intrahepatic Murine CD8 T-Cell Activation Associates With a Distinct Phenotype Leading to Bim-Dependent Death. Gastroenterology, 135(3), 989-997. [More Information]
  • Holz, L., McCaughan, G., Benseler, V., Bertolino, P., Bowen, D. (2008). Liver tolerance and the manipulation of immune outcomes. Inflammation and Allergy: Drug Targets, 7(1), 6-18. [More Information]
  • Vadas, M., Xia, P., McCaughan, G., Gamble, J. (2008). The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction? BBA - Bioenergetics, 1781 (9), 442-447. [More Information]

2007

  • Haber, P., McCaughan, G. (2007). "I'll never touch it again, doctor!" - harmful drinking after liver transplantation. Hepatology, 46(4), 1302-1304. [More Information]
  • McCaughan, G., Omata, M., Amarapurkar, D., Bowden, S., Chow, W., Chutaputti, A., Dore, G., Gane, E., Guan, R., Hamid, S., et al (2007). Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 22(5), 615-633. [More Information]
  • van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
  • Labio, E., Del Rosario, D., Strasser, S., McCaughan, G., Crawford, B. (2007). Effect of Ascites on Bone Density Measurement in Cirrhosis. Journal of Clinical Densitometry: Assessment of Skeletal Health, 10(4), 391-394. [More Information]
  • McCaughan, G., Shackel, N., Williams, R., Seth, D., Haber, P., Gorrell, M. (2007). Genomics, gene arrays and proteomics in the study of liver disease. In Juan Rodes, Jean-Pierre Benhamou, Andres Blei, Juerg Reichen, and Mario Rizzetto (Eds.), The Textbook of Hepatology: From Basic Science to Clinical Practice, (pp. 398-420). USA: Blackwell Publishers.
  • Cua, I., Hui, J., Bandara, P., Kench, J., Farrell, G., McCaughan, G., George, J. (2007). Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology, 46(1), 66-73. [More Information]
  • Shackel, N., McCaughan, G. (2007). Intrahepatic interferon-stimulated gene responses: Can they predict treatment responses in chronic hepatitis C infection? Hepatology (Baltimore Md.), 46(5), 1326-8. [More Information]
  • Warner, F., Lubel, J., McCaughan, G., Angus, P. (2007). Liver fibrosis: a balance of ACEs? Clinical Science, 113(3), 109-118. [More Information]
  • Perry, J., Charlton, B., Koorey, D., Waugh, R., Gallagher, P., Crawford, M., Verran, D., McCaughan, G., Strasser, S. (2007). Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International, 27(9), 1240-1248. [More Information]
  • Kubitskiy, A., Li, J., Lanzetta, M., Owen, E., McCaughan, G., Bishop, A. (2007). Simultaneous Vascularized Bone Marrow Transplantation to Promote Acceptance of Hind Limb Allografts and Its Effects on Central and Peripheral Chimerism. Transplantation, 83(9), 1273-1276. [More Information]
  • Lanzetta, M., Kubitskiy, A., Bishop, A., Li, J., McCaughan, G. (2007). Simultaneous vascularized bone marrow transplantation to promote acceptance of limb allografts. In Lanzetta M; Dubernard J (Eds.), Hand Transplantation, (pp. 57-59). Italy: Springer.
  • Benseler, V., McCaughan, G., Schlitt, H., Bishop, A., Bowen, D., Bertolino, P. (2007). The liver: a special case in transplantation tolerance. Seminars in Liver Disease, 27(2), 194-213. [More Information]
  • Shackel, N., McCaughan, G. (2007). Treatment for Cirrhosis-Associated Hyponatremia? Vaptans and Aquaresis. Hepatology, 45, 1080-1081. [More Information]
  • Haber, P., McCaughan, G., Shaw, D., Matthews, G., Hellard, M., Dore, G., Lloyd, A., Kaldor, J., Rowlinson, W., Ffrench, R. (2007). Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the australian trial in acute hepatitis C (ATAHC). The 58th Annual Meeting of the American Association for the Study of Liver Diseases, United States of America: John Wiley & Sons.
  • Huang, X., McCaughan, G., Shackel, N., Gorrell, M. (2007). Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis. Liver International, 27(7), 960-968. [More Information]

2006

  • Sadeghi, A., Xiao, C., Sharland, A., Allen, R., McCaughan, G., Bishop, A. (2006). Cytokine common gamma chain expression and its relation to liver transplant tolerance and rejection in a rat model. Immunology and Cell Biology, 84(1), A30-A30.
  • Heyman, J., Whitfield, C., Brock, K., McCaughan, G., Donaghy, A. (2006). Dietary protein intakes in patients with hepatitic encephalopathy and cirrhosis: current practice in NSW and ACT. Medical Journal of Australia, 185(10), 542-543. [More Information]
  • Yu, M., Wang, X., Ajami, K., McCaughan, G., Gorrell, M. (2006). DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis. Advances in Experimental Medicine and Biology, 575, 63-72. [More Information]
  • Wang, C., Cordoba, S., Bertolino, P., Alexander, S., Wu, M., Allen, R., McCaughan, G., Bishop, A. (2006). Examination of the immune mechanism of spontaneous tolerance of renal allografts in a mouse model. Immunology and Cell Biology, 84(1), A29-30.
  • Wang, X., Yu, M., McCaughan, G., Gorrell, M. (2006). Extra-enzymatic roles of DPIV and FAP in cell adhesion and migration on collagen and fibronectin. Advances in Experimental Medicine and Biology, 575, 213-222. [More Information]
  • Yu, M., Wang, X., McCaughan, G., Gorrell, M. (2006). Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. The FEBS Journal, 273(11), 2447-2460. [More Information]
  • Benseler, V., Holz, L., Schlitt, H., Brinkmann, V., McCaughan, G., Bertolino, P. (2006). FTY720 treatment leads to sequestration but not accumulation of antigen-specific CD8+ T cells activated in lymph nodes.
  • Cordoba, S., Wang, C., Williams, R., Li, J., Smit, L., Sharland, A., Allen, R., McCaughan, G., Bishop, A. (2006). Gene array analysis of a rat model of liver transplant tolerance identifies increased complement C3 and the STAT-1/IRF-1 pathway during tolerance induction. Liver Transplantation, 12(4), 636-643. [More Information]
  • Loss, M., Ng, W., Karim, R., Strasser, S., Koorey, D., Gallagher, P., Verran, D., McCaughan, G. (2006). Hereditary lysozyme amyloidosis: Spontaneous hepatic rupture (15 years apart) in mother and daughter. Role of emeregency liver transplantation. Liver Transplantation, 12(7), 1152-1155. [More Information]
  • Seth, D., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2006). Identification of novel therapeutic targets for alcoholic liver disease. International Society for Biomedical Research on Alcoholism World congress on Alcohol Research (ISBRA 2006), Maryland: Wiley-Blackwell Publishing.
  • Dahlke, M., Loi, R., Warren, A., Holz, L., Popp, F., Weiss, D., Piso, P., Bowen, D., McCaughan, G., Schlitt, H., Bertolino, P. (2006). Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cells. Journal of Hepatology, 44(2), 334-341. [More Information]
  • Lam, V., Laurence, J., Sharland, A., McCaughan, G., Hodgkinson, S., Hall, B., Allen, R., Bishop, A. (2006). Induction of long-term cardiac allograft survival using anti-lymphocyte antibodies in the rat model. Immunology and Cell Biology, 84(1), A27-A27.
  • Seth, D., Gorrell, M., Cordoba, S., McCaughan, G., Haber, P. (2006). Intrahepatic gene expression in human alcoholic hepatitis. Journal of Hepatology, 45(2), 306-320. [More Information]
  • Cua, I., Hui, J., Bandara, P., Kench, J., McCaughan, G., George, J. (2006). Is insulin resistance and liver injury in chronic hepatitis C associated with virus-specific alteration in the levels of serum adipocytokines? Journal of Gastroenterology and Hepatology, 21, A22-A22.
  • St George, A., Johnston, A., Bauman, A., Iverson, D., Tapsell, L., McCaughan, G., Strasser, S., McGrath, L., Green, J., Farrell, G., George, J. (2006). Lifestyle intervention in early liver disease: metabolic changes at 3 months. Journal of Gastroenterology and Hepatology, 21(Suppl. 4), A315.
  • Prakoso, E., Strasser, S., Koorey, D., Verran, D., McCaughan, G. (2006). Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation, 20(3), 369-373. [More Information]
  • Bertolino, P., McCaughan, G., Le Couteur, D., Warren, A., Fraser, R., Benseler, V. (2006). Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. Journal of Hepatology, 46, 239-246. [More Information]
  • Benseler, V., Cordoba, S., Wang, C., Zvolynska, A., Sharland, A., Shlitt, H., McCaughan, G., Allen, R., Bishop, A. (2006). Microarray analysis of spontaneously tolerant compared to rejecting rat liver allografts. Immunology and Cell Biology, 84(1), A31-A32.
  • Chen, T., Ajami, K., McCaughan, G., Gai, W., Gorrell, M., Abbott, C. (2006). Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activity. BBA - Bioenergetics, 1764 (1), 33-43. [More Information]
  • Seth, D., Beard, M., Gorrell, M., McCaughan, G., Haber, P. (2006). Osteopontin: An early marker for alcoholic liver injury? Alcoholism: Clinical and Experimental Research, 30(s2), 89A-89A.
  • Kelly, M., Chick, J., Gribble, R., Gleeson, M., Holton, M., Winstanley, J., McCaughan, G., Haber, P. (2006). Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol and Alcoholism, 41(3), 278-283.
  • Buchanan, A., Wang, C., Tran, G., Hodgkinson, S., Hall, B., McCaughan, G., Allen, R., Bishop, A. (2006). Role of IL-4 in rat liver allograft rejection. Immunology and Cell Biology, 84(1 Supplement), A28-A28.
  • Kubitskiy, A., Lanzetta, M., Owen, E., McCaughan, G., Bishop, A. (2006). Simultaneous vascularised bone marrow transplantation to promote acceptance of hind limb allografts. Immunology and Cell Biology, 84(Supplement 1), A30-A30.
  • Gorrell, M., Wang, X., Park, J., Ajami, K., Yu, M., Knott, H., Seth, D., McCaughan, G. (2006). Structure and function in dipeptidyl peptidase IV and related proteins. Advances in Experimental Medicine and Biology, 575, 45-54. [More Information]
  • Warren, A., Le Couteur, D., Fraser, R., Bowen, D., McCaughan, G., Bertolino, P. (2006). T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology, 44(5), 1182-1190. [More Information]
  • Shackel, N., Seth, D., Haber, P., Gorrell, M., McCaughan, G. (2006). The hepatic transcriptome in human liver disease. Comparative Hepatology, 5, 6-6. [More Information]
  • Cordoba, S., Wang, C., Sharland, A., McCaughan, G., Allen, R., Bishop, A. (2006). Transcriptomics of tolerant and rejecting renal allografts. Immunology and Cell Biology, 84(1), A2-A2.
  • Crawford, B., Labio, E., Strasser, S., McCaughan, G. (2006). Vitamin D replacement for cirrhosis-related bone disease. Nature Clinical Practice Gastroenterology and Hepatology, 3(12), 689-699. [More Information]
  • Crawford, B., Kam, C., Pavlovic, J., Byth Wilson, K., Handelsman, D., Angus, P., McCaughan, G. (2006). Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 144(4), 239-248. [More Information]

2005

  • Bandara, P., George, J., McCaughan, G., Naidoo, D., Lux, O., Salonikas, C., Kench, J., Byth Wilson, K., Farrell, G. (2005). Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C. Liver International, 25(3), 518-526. [More Information]
  • Bertolino, P., Bowen, D., Zen, M., McCaughan, G. (2005). Autoimmune hepatitis in transgenic mouse models: what lessons can be learnt? In H. P. Dienes, U. Leuschner, A. W. Lohse, M. P. Manns (Eds.), Autoimmune Liver Disease: Proceedings of the Falk Symposium No. 142, (pp. 60-72). The Netherlands: Springer.
  • Perry, J., Poustchi, H., George, J., Farrell, G., McCaughan, G., Strasser, S. (2005). Current approaches to the diagnosis and management of hepatocellular carcinoma. Clinical and Experimental Medicine, 5(1), 1-13. [More Information]
  • Geier, M., Tenikoff, D., Yazbeck, R., McCaughan, G., Abbott, C., Howarth, G. (2005). Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV. Journal of Cellular Physiology, 204(2), 687-692. [More Information]
  • Benseler, V., Bishop, A., Chng, K., Watson, J., Wang, C., Dahlke, M., Koutalistras, N., Watts, A., Hawthorne, W., McKenzie, P., Hennessy, A., Pleass, H., Chadban, S., Schlitt, H., McCaughan, G., et al (2005). Development of a primate model to evaluate strategies to achieve long term renal allograft acceptance. Immunology and Cell Biology, 83(4 Suppl.), A26-A26.
  • Kanatani, T., Lanzetta, M., Owen, E., Matsumoto, T., Fujioka, H., Kurosaka, M., McCaughan, G., Bishop, A. (2005). Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. Transplantation Proceedings, 37(5), 2382-2384. [More Information]
  • Bertolino, P., Schrage, A., Bowen, D., Klugewitz, K., Ghani, S., Eulenburg, K., Holz, L., Hogg, N., McCaughan, G., Hamann, A. (2005). Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice. Hepatology, 42(5), 1063-1071. [More Information]
  • Cordoba, S., Wang, C., Li, J., Bertolino, P., McCaughan, G., Bishop, A. (2005). Examination of immune mechanisms in a mouse model of spontaneous renal allograft acceptance. Immunology and Cell Biology, 83(4 Supplement), A20-A21.
  • Wang, X., Yu, M., McCaughan, G., Gorrell, M. (2005). Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology, 42(4), 935-945. [More Information]
  • Adams, L., Bulsara, M., Rossi, E., DeBoer, B., Speers, D., George, J., Kench, J., Farrell, G., McCaughan, G., Jeffrey, G. (2005). Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clinical Chemistry (Washington, DC), 51(10), 1867-1873. [More Information]
  • Bowen, D., McCaughan, G., Bertolino, P. (2005). Intrahepatic immunity: a tale of two sites? Trends in Immunology, 26(10), 512-517. [More Information]
  • McCaughan, G., Koorey, D., Strasser, S. (2005). Liver transplantation for viral hepatitis. British Journal of Hospital Medicine (London), 66(1), 8-12. [More Information]
  • Tanaka, H., Verran, D., Shun, A., Dorney, S., Stormon, M., Fisher, J., McCaughan, G. (2005). Liver transplantation utilizing pediatric cadaver donor livers. Pediatric Transplantation, 9(1), 47-51. [More Information]
  • Cordoba, S., Wang, C., Williams, R., Sharland, A., McCaughan, G., Bishop, A. (2005). Meta-analysis of transcriptional profiles in three models of transplant tolerance identifies the STAT-1/IRF-1 pathway. Immunology and Cell Biology, 83(4), A31-A31.
  • Sun, J., Tumurbaatar, B., Jia, J., Diao, H., Bodola, F., Lemon, S., Tang, W., Bowen, D., McCaughan, G., Bertolino, P., et al (2005). Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury. Journal of Virology, 79(16), 10730-10739. [More Information]
  • Holz, L., Benseler, V., Gengos, M., Newtown, R., McCaughan, G., Bertolino, P. (2005). Phenotype of CD8+ T cells activated in the liver. Tissue Antigens: immune response genetics, 66(5), 444 (Abstract 279)-444.
  • Zahir, H., McLachlan, A., Nelson, A., McCaughan, G., Gleeson, M., Akhlaghi, F. (2005). Population Pharmacokinetic Estimation of Tacrolimus Apparent Clearance in Adult Liver Transplant Recipients. Therapeutic Drug Monitoring, 27(4), 422-430. [More Information]
  • Wang, C., Li, J., Cordoba, S., McLeod, D., Tran, G., Hodgkinson, S., Hall, B., McCaughan, G., Bishop, A. (2005). Posttransplant Interleukin-4 Treatment Converts Rat Liver Allograft Tolerance to Rejection. Transplantation, 79(9), 1116-1120. [More Information]
  • Wang, C., Li, J., Tran, G., Hodgkinson, S., Hall, B., McCaughan, G., Allen, R., Bishop, A. (2005). Role of IL-4 in rat liver allograft rejection. Immunology and Cell Biology, 83(4 Supplement), A11-A11.
  • Benseler, V., Warren, A., Holz, L., Gengos, M., Bowen, D., Le Couteur, D., Schlitt, H., McCaughan, G., Bertolino, P. (2005). The liver promotes antigen-specific retention and rapid clearance of naive CD8(+) T cells activated in situ. Tissue Antigens: immune response genetics, 66(5), 359-360.
  • Wang, X., Yu, D., Schnapp, A., Marguet, D., Cordoba, S., Retting, W., McCaughan, G., Gorrell, M. (2005). The role of fibroblast activation protein (FAP) in cell adhesion, migration and liver fibrosis. 56th Annual Meeting of the American Association for the Study of Liver Diseases, United States: John Wiley & Sons.
  • Cordoba, S., Wang, C., Williams, R., Sharland, A., Allen, R., McCaughan, G., Bishop, A. (2005). The STAT-1/IRF-1 signalling pathway and complement cascade are increased in rat liver transplant tolerance identified by meta-analysis of high-throughput screening techniques. Hepatology, 42(4 S1), 314A-314A.

2004

  • Zekry, A., Gleeson, M., Guney, S., McCaughan, G. (2004). A Prospective Cross-Over Study Comparing The Effect Of Mycophenolate Versus Azathioprine On Allograft Function And Viral Load In Liver Transplant Recipients With Recurrent Chronic Hcv Infection. Liver Transplantation, 10(1), 52-57. [More Information]
  • Zahir, H., McCaughan, G., Gleeson, M., Nand, R., McLachlan, A. (2004). Changes In Tacrolimus Distribution In Blood And Plasma Protein Binding Following Liver Transplantation. Therapeutic Drug Monitoring, 26(5), 506-515.
  • Den Dulk, M., Wang, C., Li, J., Clark, D., Hibberd, A., Terpstra, O., McCaughan, G., Bishop, A. (2004). Combined Donor Leucocyte Administration And Immunosuppressive Drug Treatment For Survival Of Rat Heart Allografts. Transplant Immunology, 13(3), 177-184.
  • Ajami, K., Abbott, C., McCaughan, G., Gorrell, M. (2004). Dipeptidyl Peptidase 9 Has Two Forms, A Broad Tissue Distribution, Cytoplasmic Localization And DPIV-Like Peptidase Activity. BBA - Bioenergetics, 1679 (1), 18-28. [More Information]
  • Kanatani, T., Wright, B., Lanzetta, M., Molitor, M., McCaughan, G., Bishop, A. (2004). Experimental Limb Transplantation, Part III: Induction Of Tolerance In The Rigorous Strain Combination Of Brown Norway Donor To Lewis Recipient. Transplantation Proceedings, 36(10), 3276-3282.
  • Zahir, H., McCaughan, G., Gleeson, M., Nand, R., McLachlan, A. (2004). Factors Affecting Variability In Distribution Of Tacrolimus In Liver Transplant Recipients. British Journal of Clinical Pharmacology, 57(3), 298-309.
  • McCaughan, G., George, J. (2004). Fibrosis Progression In Chronic Hepatitis C Virus Infection. Gut (English Edition): an international journal of gastroenterology and hepatology, 53(3), 318-321.
  • Sud, A., Hui, J., Farrell, G., Bandara, P., Kench, J., Fung, C., Lin, R., Samarasinghe, D., Liddle, C., McCaughan, G., George, J. (2004). Improved Prediction Of Fibrosis In Chronic Hepatitis C Using Measures Of Insulin Resistance In A Probability Index. Hepatology, 39(5), 1239-1247. [More Information]
  • Jonsson, J., Gu, W., Vanags, D., Bishop, A., McCaughan, G., Fawcett, J., Lynch, S., Balderson, G., Powell, E., Clouston, A. (2004). Increased Mononuclear Cell Activation And Apoptosis Early After Human Liver Transplantation Is Associated With A Reduced Frequency Of Acute Rejection. Liver Transplantation, 10(3), 397-403. [More Information]
  • McCaughan, G., Zekry, A. (2004). Mechanisms Of Hcv Reinfection And Allograft Damage After Liver Transplantation. Journal of Hepatology, 40(3), 368-374. [More Information]
  • Crawford, D., Fletcher, L., Hubscher, S., Stuart, K., Gane, E., Angus, P., Jeffrey, G., McCaughan, G., Kerlin, P., Powell, L., et al (2004). Patient And Graft Survival After Liver Transplantation For Hereditary Hemochromatosis: Implications For Pathogenesis. Hepatology, 39(6), 1655-1662. [More Information]
  • McCaughan, G., Bertolino, P., Bowen, D., Zen, M., Holz, L., Davis, T. (2004). The Site Of Primary T Cell Activation Is A Determinant Of The Balance Between Intrahepatic Tolerance And Immunity. Journal of Clinical Investigation, 114(5), 701-712.

2003

  • McDougall, A., Davies, L., McCaughan, G. (2003). Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle and Nerve, 28(5), 595-600. [More Information]
  • Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., McCaughan, G. (2003). Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplantation, 9(5), 500-505.
  • Chen, T., Ajami, K., McCaughan, G., Gorrell, M., Abbott, C. (2003). Dipeptidyl peptidase IV gene family. In M. Hildebrandt, B. F. Klapp, T. Hoffman and H.-U. Demuth (Eds.), Dipeptidyl Aminopeptidases in Health and Disease, (pp. 79-88). NY: Springer.
  • Seth, D., Leo, M., McGuinness, P., Lieber, C., Brennan, Y., Williams, R., Wang, X., McCaughan, G., Gorrell, M., Haber, P. (2003). Gene expression profiling of alcoholic liver disease in the Baboon (Papio hamadryas) and human liver. The American Journal of Pathology: cellular and molecular biology of disease, 163(6), 2303-2317.
  • McCaughan, G., Zekry, A. (2003). Impact of immunosuppression on immunopathogenesis of liver damage in Hepatitis C virus-infected recipients following liver transplantation. Liver Transplantation, 9(11), S21-S27.
  • Hui, J., Sud, A., Farrell, G., Bandara, P., Byth Wilson, K., Kench, J., McCaughan, G., George, J. (2003). Insulin resistance is associated with chronic Hepatitis C and virus infection fibrosis progression. Gastroenterology, 125(6), 1695-1704.
  • Gorrell, M., Wang, X., Levy, M., Kable, E., Marinos, G., Cox, G., McCaughan, G. (2003). Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infection. In M. Hildebrandt, B. F. Klapp, T. Hoffman and H.-U. Demuth (Eds.), Dipeptidyl Aminopeptidases in Health and Disease, (pp. 235-243). NY: Springer.
  • Ajami, K., Abbott, C., Gysbers, V., Kaehne, T., McCaughan, G., Gorrell, M. (2003). Molecular chimeras and mutational analysis in the prolyl oligopeptidase gene family. In M. Hildebrandt, B. F. Klapp, T. Hoffman and H.-U. Demuth (Eds.), Dipeptidyl Aminopeptidases in Health and Disease, (pp. 49-55). NY: Springer.
  • Shackel, N., McGuiness, P., Abbott, C., Gorrell, M., McCaughan, G. (2003). Novel differential gene expression in human cirrhosis detected by suppression substractive hybridization. Hepatology, 38(3), 577-588.
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive Transfer of Nut Allergy After Liver Transplantation. Archives of Internal Medicine, 163(2), 237-239.
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive transfer of nut allergy after liver transplantation. Archives of Internal Medicine, 163(2), 237-239.
  • Haber, P., Warner, R., Seth, D., Gorrell, M., McCaughan, G. (2003). Pathogenesis and management of alcoholic hepatitis. Journal of Gastroenterology and Hepatology, 18(12), 1332-1344.
  • Perry, J., Strasser, S., George, J., Farrell, G., McCaughan, G. (2003). Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy, 4(12), 2175-2185.
  • Seth, D., Gorrell, M., McGuiness, P., Leo, M., Lieber, C., McCaughan, G., Haber, P. (2003). SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. Journal Of Biochemical and Biophysical Methods, 55(1), 53-66.
  • Ajami, K., Abbott, C., Obradovic, M., Gysbers, V., Kahne, T., McCaughan, G., Gorrell, M. (2003). Structural requirements for catalysis, expression, dimerization in the CD26/DPIV gene family. Biochemistry, 42(3), 694-701.
  • Crawford, B., Kam, C., Donaghy, A., McCaughan, G. (2003). The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporosis International, 14(12), 987-994. [More Information]

2002

  • Bowen, D., Warren, A., Davis, T., Hoffmann, M., McCaughan, G., Fazekas, B., Bertolino, P. (2002). Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8+ T-cell activation by bone marrow-derived cells. Gastroenterology, 123(4), 1252-1264.
  • Yin, J., Pilmore, H., Yan, Y., McCaughan, G., Bishop, A., Hambly, B., Eris, J. (2002). Expression of growth arrest-specific gene 6 and its receptors in a rat model of chronic renal transplant rejection. Transplantation, 73(4), 657-660.
  • Shackel, N., Gorrell, M., McCaughan, G. (2002). Gene array analysis and the liver. Hepatology, 36(6), 1313-1325.
  • McCaughan, G., Koorey, D., Strasser, S. (2002). Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal, 32(8), 394-400.
  • Shackel, N., McGuinness, P., Abbott, C., Gorrell, M., McCaughan, G. (2002). Insights into the pathobiology of hepatitis C virus-associated cirrhosis. The American Journal of Pathology: cellular and molecular biology of disease, 160(2), 641-654.
  • Zekry, A., Bishop, A., Bowen, D., Gleeson, M., Guney, S., Painter, D., McCaughan, G. (2002). Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transplantation, 8(3), 292-301.
  • Levy, M., McCaughan, G., Marinos, G., Gorrell, M. (2002). Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver International, 22(2), 93-101.
  • McCaughan, G., Zekry, A. (2002). Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transplantation, 8(10B), S7-S13.
  • Yan, Y., Putten, K., Bowen, D., Painter, D., Kohar, J., Sharland, A., McCaughan, G., Bishop, A. (2002). Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with TH2 cytokine expression in long-term accepted grafts. Transplantation, 73(7), 1123-1130.
  • McDougall, A., Davies, L., McCaughan, G. (2002). Rapid improvement of autonomic and peripheral neuropathy after liver transplantation: a single case report. Liver Transplantation, 8(2), 164-166.
  • Bertolino, P., McCaughan, G., Bowen, D. (2002). Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'. Immunology and Cell Biology, 80(1), 84-92.
  • Bishop, A., Wang, C., Sharland, A., McCaughan, G. (2002). Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect. Immunology and Cell Biology, 80(1), 93-100.
  • Pilmore, H., Yan, Y., Eris, J., Hennessy, A., McCaughan, G., Bishop, A. (2002). Time course of upregulation of fibrogenic growth factors and cellular infiltration in a rodent model of chronic renal allograft rejection. Transplant Immunology, 10(4), 245-254.
  • McCaughan, G. (2002). Withdrawal of immunosuppression in liver transplant recipients: is this as good as it gets. Liver Transplantation, 8(4), 408-410.

2001

  • Wang, C., Sun, J., Sheil, A., McCaughan, G., Bishop, A. (2001). A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation, 72(1), 44-51.
  • Haber, P., Nakamura, M., Tsuchimoto, K., Ishii, H., Keogh, G., Apte, M., Moran, C., Stewart, N., Crawford, D., Pirola, R., McCaughan, G., Ramm, G., Conigrave, K., et al (2001). Alcohol and the pancreas. Alcoholism: Clinical and Experimental Research, 25, 244S-250S.
  • Bertolino, P., Bowen, D., McCaughan, G., Fazekas, B. (2001). Antigen-Specific Primary Activation of CD8(+) T Cells Within the Liver. Journal of Immunology, 166, 5430-5438.
  • Shackel, N., McGuinness, P., Abbott, C., Gorell, M., McCaughan, G. (2001). Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut (English Edition): an international journal of gastroenterology and hepatology, 49, 565-576.
  • Bishop, A., McCaughan, G. (2001). Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy. Liver Transplantation, 7(3), 161-172.
  • Verran, D., Gurkan, A., Dilworth,, P., Painter, D., Chui,, A., Dorney, S., Shun, A., Koorey, D., McCaughan, G., Sheil, A. (2001). Inferior liver allograft survival from cadaveric donors > 50 years of age? Clinical Transplantation, 15(2), 106-110.
  • Koorey, D., McCaughan, G., Sheil, A., Verran, D., Gurka, J., Dilworth,, P., Painter, D., Chui,, A., Dorney, S., Shun, A. (2001). Inferior liver allograft survivial from cadaveric donors: > 50 years of age? Clinical Transplantation, 15, 106-110.
  • Yan, Y., Shastry, S., Richards, C., Wang, C., Bowen, D., Sharland, A., Painter, D., McCaughan, G., Bishop, A. (2001). Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. Journal of Immunology, 166, 5258-5264.
  • Yin, J., Shackel, N., Zekry, A., McGuinness, P., Richards, C., van der Putten, K., McCaughan, G., Eris, J., Bishop, A. (2001). Real-time reverse transcriptases-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green 1. Immunology and Cell Biology, 79(3), 213-221.

2000

  • Doran, T., Geczy, A., Painter, D., McCaughan, G., Sheil, A., Susal, C., Opelz, G. (2000). A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation, 69(7), 1491-1498.
  • Chui, A., Shi, L., Rao, A., Verran, D., Painter, D., Koorey, D., McCaughan, G., Sheil, A. (2000). Donor Fatty (Steatotic) Liver Allografts in Orthotopic Liver Transplantation: A Revisit. Transplantation Proceedings, 32(7), 2101-2102.
  • Pilmore, H., Painter, D., Bishop, A., McCaughan, G., Eris, J. (2000). Early up-regulation of macrophages and myofibroblasts. Transplantation, 69(12), 2658-2662.
  • Latt, N., Spencer, D., Beeby, P., McCaughan, G., Saunders, J., Collins,, E., Cossart, Y. (2000). Hepatitis C in injecting drug-using women during and after pregnancy. Journal of Gastroenterology and Hepatology, 15, 175-181.
  • Chui, A., Rao, A., Waugh, R., Mayr, M., Verran, D., Koorey, D., McCaughan, G., Ong, J., Sheil, A. (2000). Liver transplantation in patients with transjugular intrahepatic portosystemic shunts. ANZ Journal of Surgery, 70(7), 493-495.
  • McCaughan, G., Gorrell, M., Bishop, A., Abbott, C., Shackel, N., McGuinness, P., Levy, M., Sharland, A., Bowen, D., Yu, M., Slaitini, L., Napoli, J., et al (2000). Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunological Reviews, 174(1), 172-191.
  • Rao, A., Chui, A., Gurkan, A., Shi, L., Al-harbi, I., Waugh, R., Verran, D., McCaughan, G., Koorey, D., Sheil, A. (2000). Orthotopic Liver Transplantation for Treatment of Patients With Budd–Chiari Syndrome: A Singe-Center Experience. Transplantation Proceedings, 32(7), 2206-2207.
  • Verran, D., Gurkan, A., Chui, A., Dilworth,, P., Koorey, D., McCaughan, G., Sheil, A. (2000). Pancreatitis in adult orthotopic liver allograft recipients: risk factors and outcome. Liver Transplantation, 6, 632-366.
  • Chui, A., Shi, L., Rao, A., Anasuya, A., Hagi, C., Pillay, P., Verran, D., McCaughan, G., Sheil, A. (2000). Primary Graft Dysfunction After Liver Transplantation. Transplantation Proceedings, 32(7), 2219-2220.

To update your profile click here. For support on your academic profile contact .